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The immune system and nervous system are tightly connected, but this intricate interplay 
is not yet fully understood. This study aimed to elucidate the influence of the sympathetic 
nervous system on leukocyte trafficking in vivo. Using adoptive transfers combined with 
flow cytometry as well as intravital imaging, it was demonstrated that adrenergic 
stimulation – predominantly mediated by 2-adrenoceptors – affected neutrophils and B 
cells differently. Neutrophils accumulated in the circulation, due to impaired recruitment. 
This was accompanied by reduced expression of adhesion molecules on the surface of 
these cells. Furthermore, it was shown that neutrophil-intrinsic as well as 2-
adrenoceptors of the microenvironment were involved. The 3-adrenoceptor agonist 
BRL37344 was found to have rather unspecific effects in blood, whereas in the bone 
marrow it could be mediating the mobilization of neutrophils. B cell numbers were 
reduced in blood upon treatment with the 2-adrenoceptor agonist Clenbuterol, which 
was ratified as 2-adrenoceptor specific. It could be shown that B cells were homing 
slightly better to lymph nodes, where they were retained and thus could not reenter the 
circulation. This process was likely mediated by integrins, as block of CD62L did not 
counteract the reduction in blood. Moreover, adrenergic stimulation led to an activated 
state of B cells, as evidenced by upregulated surface levels of adhesion molecules. For the 
first time, this study shows an extensive screen of neutrophil and B cell distributions 
under adrenergic control, perpetuating existing data and confirming that immune cell 
trafficking is under control of the sympathetic nervous system. This fact will be important 
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   Introduction 
1.1 Explanatory statement 
 
An organism only functions properly when its constituting components are working 
together in harmony. Two of these major key players are the nervous system and the 
immune system. Functioning consciously as well as unconsciously, the nervous system 
senses, interprets and responds to proceedings in the environment. The immune system 
is not only responsible for host protection against foreign pathogens by initiation of 
inflammation, but also for the maintenance of its equilibrium by regulating processes like 
tissue regeneration. The immune system and nervous system are tightly interconnected 
during inflammation and homeostasis, in which the sympathetic nervous system plays a 
decisive role (Elenkov et al., 2000). To understand the intricate neuro-immune interplay, 
the migratory behavior of immune cells under stress is a fascinating aspect to investigate. 
Immune cell trafficking is crucial for development, immune-surveillance and effector 
function and takes place between lymphoid organs, the circulation and peripheral tissues. 
Therefore, it is essential that circulating cell numbers are tightly regulated, as 
malfunctions can lead to severe diseases.  
Despite a plethora of studies investigating the complex interactions between the 
sympathetic nervous system and the immune system (Jakob et al., 2020; Nance and 
Sanders, 2007), they are only partly understood. Thus, the focus of this thesis lies on 
adrenergic effects on leukocyte migration in vivo under steady-state conditions. Only after 
understanding when and where leukocytes are located under physiological stress signals, 
therapies can effectively target dysfunctions of these processes. Based on previous 
findings regarding the influence of adrenergic stimuli on the distribution of immune cells 
in the mouse (Scheiermann et al., 2012), this thesis is about the migratory behavior of 
murine neutrophils and B cells – as representatives of innate and adaptive immunity, 





1.2 The immune system requires leukocyte trafficking 
 
Every organism is constantly exposed to pathogens and hence, had to develop an efficient 
defense machinery – the immune system. It is subdivided into innate and adaptive 
immunity, of which both depend on the activity of white blood cells, the leukocytes. These 
immune cells develop and differentiate from progenitors in primary lymphoid organs, 
travel through the circulation and enter secondary lymphoid tissues where they 
encounter antigens and are activated. Fetal immune cell differentiation starts in the aorta-
gonad-mesonephros (AGM) region (Medvinsky and Dzierzak, 1996; Müller et al., 1994) 
followed by the fetal liver and is shifted to the bone marrow (BM) and thymus around 
birth, making these the most important primary lymphoid organs. Secondary lymphoid 
organs comprise lymph nodes (LNs), the spleen and Peyer´s patches, the latter associated 
with the small intestine. However, immune cells do not exclusively patrol these organs 
since every tissue has to be equipped with protective mechanisms against intrinsic and 
extrinsic hazards as well as maintenance of homeostatic processes.  
Innate immunity builds the first, relatively unspecific line of defense against inflammatory 
insults. It comprises granulocytes (neutrophils, eosinophils, basophils), monocytes, 
dendritic cells (DCs), natural killer (NK) and natural killer T (NKT) cells, that scan the body 
for multiple endogenous and exogenous factors, eliminate pathogens, take up foreign 
antigen and present it to cells of the adaptive immune system. Additionally, invariant T 
cells interlink innate and adaptive immunity as unique innate-like cells (Toubal et al., 
2019). Adaptive immunity creates the immunological memory to effectively fight re-
occurring threats with the help of B and T lymphocytes. Thus, for cell interactions as well 
as exertion of effector function cell types of both arms of immunity have to travel to 
peripheral organs, where they adhere and migrate across the vascular endothelium – a 
process called leukocyte trafficking.  
Leukocyte trafficking is orchestrated by various factors, such as endothelial architecture, 
chemokine composition and blood flow rate. Another aspect gaining in importance is the 
time of day. Peripheral blood leukocyte counts oscillate throughout the day, showing a 
peak during the behavioral resting phase (Druzd et al., 2017; He et al., 2018; Scheiermann 
et al., 2012). On the other hand, during the active phase of an organism, leukocytes 
predominantly immigrate into peripheral tissues, based on changing expression profiles 
of adhesion molecules on leukocytes as well as endothelial cells (ECs) (He et al., 2018). 
Depending on their functions, leukocyte subsets circulate the body following specific 




stimulation, thus conventional migratory routes during the life time of these cell types are 
outlined in the following paragraphs. 
 
1.2.1 The life cycle of neutrophils 
Neutrophils are the most abundant leukocyte subset in the human circulation, whereas 
they only make up 30% of the leukocyte composition in murine blood. These granulocytes 
are an important cell type of the innate immune system, as they fight pathogens via 
phagocytosis (Lee et al., 2003), the release of neutrophil extracellular traps (NETs) 
(Papayannopoulos, 2018), reactive oxygen species (ROS) formation (Babior et al., 1973), 
and the release of granules (Yin and Heit, 2018). Moreover, they aid in tissue repair after 
an injury while they can also cause tissue damage (Wang, 2018). Due to their crucial role 
in these processes, the regulation of their circulating numbers is essential. Neutrophils 
develop from a myeloid progenitor in the BM as primary production site, in which pre-
mature cells reside in specialized niches (Birbrair and Frenette, 2016). Rhythmically 
during homeostasis or as response to an inflammatory stress, mature cells are released 
into the circulation (Furze and Rankin, 2008) and migrate to peripheral tissues to fulfill 
their tasks. Afterwards, cells either undergo apoptosis at the same site and get eliminated 
by tissue resident macrophages, or they migrate to the marginal pool in the lung, where 
they upregulate age-related markers, leading them back to the BM for clearance (Hidalgo 
et al., 2019). After their relatively short life in the circulation (Pillay et al., 2010) 
neutrophils under non-inflammatory conditions are also cleared in spleen and liver 
(Furze and Rankin, 2008). Although neutrophils have been seen as homogenous 
population, increasing evidence hints to multiple existing phenotypes exhibiting various 
functions in health and disease (Hellebrekers et al., 2018).  
 
1.2.2 The life cycle of B cells 
B cells are essential cellular components of the adaptive immunity, since they respond to 
specific antigenic epitopes by production of antibodies, thereby providing a specialized 
defense against pathogens. Together with T cells, they account for the main part of murine 
blood leukocytes. B cell development undergoes multiple phases beginning in primary 
lymphoid tissues and continuing with functional maturation in secondary lymphoid 
tissues, which constantly receive antigen through circulating lymph. In the spleen, mature 
B cells reside within lymphoid follicles, where DCs present the foreign antigen to 




antibody-secreting plasma cells and memory B cells (Eibel et al., 2014), which migrate to 
peripheral tissues where they mediate adaptive humoral responses. In addition, naïve B 
cells home to the BM, where they form perisinusoidal niches in which they undergo T cell-
independent maturation processes (Cariappa et al., 2007). Next to their role in host 
defense, they are responsible for lymphoid tissue organogenesis, wound healing, DC 
regulation and co-stimulation of as well as antigen presentation to T cells (LeBien and 
Tedder, 2008). 
 
1.2.3 Leukocyte trafficking depends on adhesion molecules 
For leukocyte entry to target tissues, circulating immune cells are captured and roll along 
the endothelium, where they are activated by chemokines. After firm adhesion, leukocytes 
can crawl and eventually transmigrate. For this sequence of steps, interaction of specific 
molecules between the circulating cells and the endothelium is required. These molecules 
are generally termed adhesion molecules and include numerous protein families, which 
will be shortly introduced here and are further summarized in Table 1-1.  
One important family comprises selectins, which are expressed by ECs (E-, P-selectin) and 
leukocytes (L-selectin). These transmembrane proteins require Ca2+ to bind sialylated 
carbohydrate structures. L-selectin (CD62L) was first discovered on lymphocytes, but is 
expressed on basically all circulating leukocytes (Lewinsohn et al., 1987). Although it was 
long thought that L-selectin is only crucial in lymphocyte binding to high endothelial 
venules (HEVs), further investigation revealed its additional role in the peripheral 
microvasculature during homeostasis (Ley et al., 1993; von Andrian et al., 1991). 
Furthermore, L-selectin was found to take part in neutrophil tethering (Walcheck et al., 
1996). Protein kinase C (PKC)-dependent phosphorylation of the cytoplasmic domain of 
this selectin type is required for leukocyte rolling and adhesion to HEVs (Kansas et al., 
1993). Importantly and in contrast to other adhesion molecules, L-selectin is shed upon 
activation (Chen et al., 1995; Venturi et al., 2003).  
Another type of selectins is P-selectin (CD62P), which is constitutively expressed by 
platelets (Hsu-Lin et al., 1984) and stimulated ECs (McEver et al., 1989). After expression 
in the latter cell type, P-selectin is internalized and stored in intracellular storage 
granules, called Weibel-Palade bodies, from where it is transported to the surface upon 
stimulation. As this process is taking place in only a few minutes, P-selectin contributes to 





The third member, E-selectin (CD62E), is highly glycosylated and exclusively found on 
activated ECs (Bevilacqua et al., 1987). Its expression in the majority of organs is regulated 
by inflammatory mediators like tumor necrosis factor  (TNF), except for skin where it 
is constitutively expressed (Hwang et al., 2004). In several models of inflammation, 
neutrophil trafficking was not altered in CD62E-deficient mice until P-selectin was 
blocked, indicating a functional redundancy of these two adhesion molecules (Frenette et 
al., 1996; Labow et al., 1994). 
Among selectin ligands, P-selectin glycoprotein ligand-1 (PSGL-1, CD162) is an important 
molecule interacting with all three selectins (Moore, 1998). It plays a crucial role in 
leukocyte recruitment, as blocking by a monoclonal antibody disables binding of murine 
myeloid cells to P-selectin and thereby completely abolishes leukocyte rolling (Borges et 
al., 1997). However, in PSGL-1-deficient mice it was shown that a PSGL-1-independent, E-
selectin-dependent rolling occurs (Yang et al., 1999), which seems to be supported by 
2,3-sLex glycosphingolipids (Burdick et al., 2001). 
In blood vessels, adhesive processes of cells are predominantly mediated by the protein 
class of integrins. These adhesion molecules reside in a low-affinity state, whereas ligand 
binding leads to a high affinity confirmation (Takagi et al., 2002). On leukocytes, members 
belonging to the 2 and 7 subfamilies are expressed, which bind to endothelial adhesion 
molecules. 2-integrins are built of two subunits constituting four different heterodimers, 
namely L2 (LFA-1, CD11a/CD18), M2 (Mac-1, CD11b/CD18), x2 (CD11c/CD18) and 
D2 (CD11d/CD18). They play a major role in the firm adhesion between leukocytes and 
endothelium as well as among leukocytes (Luo et al., 2007). LFA-1 is ubiquitously 
expressed on immunocompetent cells, whereas Mac-1 is predominantly expressed on 
cells of the myeloid lineage. The 41-integrin very late antigen 4 (VLA-4)  can mediate 
rolling and adhesion of leukocytes, thus acting independently of selectins (Alon et al., 
1995).  
Another crucial family of cell surface proteins comprises intercellular cell adhesion 
molecule (ICAM) 1 and 2, which are involved in every step of neutrophil extravasation and 
can have redundant, but also specific functions. ICAM-1 is constitutively expressed on 
every blood vessel endothelium as well as in low amounts on leukocytes. The surface 
location of ICAM-1 and ICAM-2 differs in that ICAM-1 is more uniformly expressed, 
whereas ICAM-2 is clustered at cell junctions of ECs. Furthermore, during inflammation, 
ICAM-1 levels increase while ICAM-2 is downregulated (Dustin et al., 1986). Both 
adhesion molecules bind to LFA-1 and Mac-1 on leukocytes (Diamond et al., 1990; 




Vascular cell adhesion molecule (VCAM)-1 expression on ECs is inducible by several 
factors, e.g. pro-inflammatory cytokines and shear stress. Its ligands are the integrins VLA-
4 (41) and CD49d (47)(Kong et al., 2018).   
CD44 is a cell surface adhesion molecule with multiple isoforms of differing molecular 
sizes. On leukocytes the ‘standard’ isoform is expressed and transiently upregulated upon 
cell activation. The major binding partner is hyaluronic acid (HA), which is part of the 
extracellular matrix and can only be bound following activation of the endothelium 
(Mohamadzadeh et al., 1998). CD44 exhibits various functions, amongst others it is 
involved in chemokine presentation and LN homing (Naor et al., 1997). 
Junctional adhesion molecules (JAMs) belong to the immunoglobulin family that is 
important for maintenance of endothelial tight junctions. The first member discovered in 
platelets was JAM-A. Since then, JAM-B and JAM-C were found to be expressed on a variety 
of cell types, including leukocytes and ECs (Kummer and Ebnet, 2018). Non-classical 
family members are ESAM, CAR, JAM-4, and JAM-L. They can interact in cis and trans: cis 
meaning they interact with other surface proteins on the same cell and trans describes 
their interaction with molecules of adjacent cells. During inflammation, proteins of the 
JAM family interact with integrins regulating cell adhesion and signaling pathways. 
Binding of JAM-A to its ligand LFA-1 mediates leukocyte adhesion and transmigration in 
vitro (Ostermann et al., 2002). In trans, JAM-B interacts with VLA-4, whereas the major 
ligand of JAM-C is Mac-1 (Kummer and Ebnet, 2018).  
Platelet endothelial cell adhesion molecule 1 (PECAM-1, CD31) is highly expressed at 
endothelial borders and shows lower levels on leukocytes. It can form homophilic 
interactions, thereby mediating diapedesis (Muller, 2017).  
Like PECAM-1, the heavily O-glycosylated type I transmembrane protein CD99 is 
expressed on both, leukocytes and ECs and is also required for transendothelial migration, 
as the inhibition of its homophilic interactions almost completely halts the process 
(Schenkel et al., 2002).  
Vascular endothelial (VE)-cadherin belongs to the family of type II classical cadherin cell 
adhesion proteins and is expressed by a specific subset of human hematopoietic stem cells 
(HSCs) and stromal cells (Oberlin et al., 2010) as well as ECs, where it maintains their 
adhesive state via homophilic interactions (Harris and Nelson, 2010).  
Chemokines present another important class of molecules in leukocyte trafficking. This 
family of small cytokines is released by various cell types in steady state as well as in 
response to inflammatory stimuli and binds to G protein-coupled receptors (GPCRs) on 
the surface of immune cells, thus regulating chemotaxis via integrin activation. Four 




leukocyte trafficking (Olson and Ley, 2002). Close to their amino terminus, CC chemokines 
harbor two adjacent cysteine residues, CXC chemokines contain one variable and CX3C 
chemokines contain three variable amino acids between two cysteines (nomenclature, 
2001). CCR7, CXCR2, CXCR4 and CXCR5 are crucial for migration of neutrophils and B cells 
to specific organs, which will be explained in more detail in chapter 1.2.5.  
The expression patterns of adhesion molecules vary between vascular beds as well as in 
the course of a day (He et al., 2018), with higher leukocyte migration capacity during the 
night in mice due to upregulation of e.g. ICAM-1 and VCAM-1 on ECs and CD11a, CXCR4 
and CD49d on leukocytes. Furthermore, every organ shows a specific rhythmic pattern of 
molecules required to enter the tissue under homeostasis and inflammation (Pick et al., 






Table 1-1: Adhesion molecules involved in leukocyte trafficking. 




L-selectin CD62L Leukocytes PSGL-1 






Hsu-Lin et al., 
1984 
McEver et al., 
1989 
E-selectin CD62E Activated ECs PSGL-1 
Bevilacqua et al., 
1987 
PSGL-1 CD162 Leukocytes CD62L/P/E Moore, 1998 
LFA-1 L2, CD11a/CD18 Leukocytes (all) ICAM-1/2 Luo et al., 2007 
Mac-1 M2, CD11b/CD18 
Leukocytes 
(myeloid cells) 
ICAM-1/2 Luo et al., 2007 






Dustin et al., 
1986 
VCAM-1 CD106 ECs (inducible) VLA-4 Kong et al., 2018 




et al., 1998 
JAM-A CD321 Leukocytes, ECs 
cis/trans: LFA-1 
JAM-A 
Ostermann et al., 
2002 













PECAM-1 Muller, 2017 
CD99 MIC2 Leukocytes, ECs CD99 









Oberlin et al., 
2010 









1.2.4 The conventional leukocyte adhesion cascade 
The infiltration of vascular beds under homeostatic and inflammatory conditions is highly 
regulated and consists of a series of adhesive steps described as the leukocyte adhesion 
cascade (Ley et al., 2007; Nourshargh and Alon, 2014) (Figure 1-1). It is mediated by an 
interplay of the molecules described in chapter 1.2.3 and starts with the reversible 
capture of leukocytes on the endothelium of postcapillary venules, mediated by PSGL-1 
interactions with endothelial E- and P-selectin. Next to PSGL-1, E-selectin ligand (ESL)-1 
on neutrophils also binds to CD44 (Hidalgo et al., 2007). More circulating leukocytes can 




1996). In contrast to fast rolling occurring without cytokine stimulation, L-selectin-
mediated slow rolling, facilitated by ICAM-1 and partly activated LFA-1 as well as the 
formation of leukocyte microvilli, increases the time for ligand presentation to chemokine 
receptors and integrins (Chen and Springer, 1999). The crucial integrins LFA-1 and Mac-
1 bind to ICAM-1 and ICAM-2, resulting in loose adhesion (Hogg et al., 2002). The 
subsequent strengthening of adhesion requires activation of LFA-1, a process depending 
on talin-1 and kindlin-3 as well as chemokines and chemoattractants (such as IL-8), 
induced by inflammatory mediators (Lefort et al., 2012). On the other hand, VCAM-1 is 
recognized by monocytes and lymphocytes expressing VLA-4 (Elices et al., 1990). After 
arrest, leukocytes either reorganize their cytoskeleton (Hyun et al., 2012) to crawl along 
the EC barrier in search for exit signals, a process depending on integrins (Phillipson et 
al., 2009), or they pass through the endothelium directly. It was long thought that, unlike 
the preceding steps, diapedesis was the only non-reversible process. However, recent 
studies demonstrated reverse migration processes of leukocytes (Nourshargh et al., 
2016). Penetration of the endothelial barrier can occur through the body of ECs 
(transcellular), but is mostly observed through junctions between adjacent cells 
(paracellular), where proteins like JAM-A and -C are concentrated (Muller, 2011). PECAM-
1 plays an essential role in an early step of transmigration, as antibodies almost 
completely block this process (Muller et al., 1993). In a later step, homophilic interactions 
of CD99 on both sides are required for transmigration of neutrophils (Lou et al., 2007). 
VE-cadherin negatively regulates transmigration and has to relocate from the junctions 
where leukocytes migrate through (Shaw et al., 2001). Presumably, numerous other 






Figure 1-1: The conventional leukocyte adhesion cascade. 
Circulating leukocytes are captured by interaction of PSGL-1 with CD62P/E on the endothelium. 
By interaction of LFA-1 and ICAM-1 leukocytes roll along the endothelial layer until they adhere, 
again mediated by integrins and endothelial ICAM-1/2 or VCAM-1. With the help of chemokines 
and chemoattractants such as IL-8, leukocytes are activated and adhere more firmly. Afterwards, 
they crawl along the endothelium in search for a suitable exit site, where they transmigrate. This 
process is mediated by homophilic interactions of PECAM-1 and CD99, as well as interactions 
between integrins and endothelial adhesion molecules such as JAM-A. 
 
1.2.5 Organ- and cell type-specific leukocyte trafficking 
The cascade paradigm described in chapter 1.2.4 has been studied mostly in the cremaster 
muscle, but is not applicable to every tissue in the body. The tissue environment and 
leukocyte subset define which adhesion molecules are involved in the interaction between 
leukocytes and the endothelium. Notably, every organ harbors specialized tissue resident 
cells that express various factors, thereby regulating leukocyte trafficking in an organ-
specific manner.  
Here, I will focus on trafficking of B cells and neutrophils, which are mostly recruited to 
the BM, LNs, lung, liver, and spleen (He et al., 2018). Thus, trafficking mechanisms in these 




cell trafficking is a continual process, little is known about homeostatic mechanisms for 
leukocyte migration in the lung and liver, as these were predominantly investigated in the 
context of inflammation or injury. Thus, although the experimental focus of this study lies 
on processes under non-inflammatory conditions, adhesive mechanisms during 
inflammation are also introduced. 
 
1.2.5.1 Bone marrow 
As a major component of innate immunity, numbers of short-lived neutrophils have to be 
constantly replenished by release from the BM, which is their production site. On the other 
hand, senescent cells have to be removed from the circulation. Thus, the BM vasculature 
has to fulfill two distinct roles, maintenance of hematopoietic stem and progenitor cells 
(HSPCs) and their release into the circulation as well as leukocyte homing for the 
degradation of neutrophils. A recent study could show that the architecture of specialized 
BM blood vessels meets the criteria for both processes, which are taking place at distinct 
sites (Itkin et al., 2016). Arterial blood vessels show lower permeability as well as ROS 
levels, thereby maintaining HSPC quiescence (Kunisaki et al., 2013). On the contrary, the 
more permeable sinusoids are the exclusive gateway of the BM. Using mixed BM chimeras, 
it could be shown that egress and homing of neutrophils are counteractively regulated by 
the chemokine receptors CXCR2 and CXCR4 (Eash et al., 2010). Furthermore, both 
processes are governed by circadian rhythms (Casanova-Acebes et al., 2013; Mendez-
Ferrer et al., 2008). The major ligand of CXCR4, CXCL12, is constitutively expressed by BM 
stromal cells and is the most important retention factor for neutrophils in mouse and 
human (Martin et al., 2003). Its expression is downregulated by the granulocyte colony-
stimulating factor (G-CSF) (Semerad et al., 2005), which also regulates neutrophil 
mobilization through CXCR2 signaling (Semerad et al., 2002). The hematopoietic cytokine 
augments CXCL1 production by ECs (Eash et al., 2010) and enhances CXCL1 release from 
BM-resident megakaryocytes, which are located in close proximity to sinusoidal vessels 
(Köhler et al., 2011).  
After about one day in the circulation, murine neutrophils upregulate ICAM-1, CD11b and 
CXCR4 levels, whereas L-selectin is progressively shed, creating a signal for these 
neutrophils to get eliminated in the BM, spleen and liver (Furze and Rankin, 2008; Martin 
et al., 2003). Importantly, oscillations in endothelial selectins and VCAM-1 expression 
influence leukocyte recruitment to the BM (Scheiermann et al., 2012), but also fluctuating 
expression levels of CXCR4 on murine neutrophils regulate their recruitment during the 




same study demonstrated a role for the previously neglected molecules L-selectin and 
ICAM-1 in BM homing of various subsets, including neutrophils and B cells (He et al., 
2018).  
 
The BM is also the production site for B cells. In specialized niches, immature B cells reside 
until they transit into sinusoids to be released into the blood stream, a process regulated 
by the sphingosine-1-phosphate (S1P) receptor (Allende et al., 2010). Similar to 
neutrophil retention, CXCL12-CXCR4 signaling was identified to be equally essential for B 
cell development (Nagasawa et al., 1996) and their retention in the BM (Ma et al., 1999). 
For homing to their tissue of origin, B cells require VCAM-1 (Koni et al., 2001), which is 
specifically involved in their adhesion and extravasation (He et al., 2018). Taken together, 
the BM is a crucial organ for homeostasis of immune cells by regulating not only their 





Figure 1-2: Leukocyte trafficking in the bone marrow. 
The high blood flow in and low reactive oxygen species (ROS) levels around arterioles maintain the 
proximal niche for hematopoietic stem and progenitor cells (HSPCs), whereas the more permeable 
sinusoids are the gateway for leukocyte trafficking. Retention of HSPCs and leukocytes is mediated 
by the CXCR4 ligand CXCL12, which is expressed by stromal cells. CXCR2 counteracts CXCR4 and is 
activated by G-CSF, resulting in cell egress. B cells leave the BM utilizing interaction of S1P and 
S1PR1. Leukocyte homing to this tissue is regulated by rhythmic expression of VCAM-1, E-selectin 
and P-selectin on sinusoidal endothelial cells, as well as upregulated adhesion molecules on 
neutrophils. 
 
1.2.5.2 Lymph nodes 
To generate adaptive immune responses, lymphocytes circulate throughout the body, 
migrate to lymph nodes where they encounter antigen conveyed by antigen presenting 
cells like DCs, enter lymphatics and eventually return to the circulation. Whereas memory 




specialized blood vessels, called HEVs (Mackay et al., 1990). HEVs are equipped with 
peripheral nodal addressins (PNAd) that are heavily modified. L-selectin recognizes the 
carbohydrate ligand 6-sulfo sialyl Lewis X (6-sulfo sLex) (Rosen, 2004) leading to 
leukocyte rolling along the endothelium. In addition, in human LNs it was shown that 
vascular adhesion protein 1 (VAP-1) mediates a lymphocyte subtype-specific, selectin-
independent interaction with the endothelium, since this monoamine oxidase binds and 
deaminates an amino group on the surface of lymphocytes, resulting in a covalent bond 
between lymphocytes and the endothelium (Salmi et al., 1997; Salmi et al., 2001). During 
rolling, lymphocytes are activated via binding of the chemokine receptors CXCR4 and 
CCR7 to their constitutively expressed ligands CXCL12 and CCL19/CCL21, respectively 
(Gunn et al., 1998; Okada et al., 2002). In contrast to T cells, B cells additionally express 
the receptor for CXCL13, CXCR5, which guides them to their target localization within the 
tissue (Girard et al., 2012). In mice, CXCL12 and CXCL13 are synthesized by LN stromal 
cells, whereas CCL21 is expressed by HEVs. Upon activation, leukocyte CD11a (LFA-1) 
interacts with endothelial ICAM-1 and ICAM-2, resulting in the successful entry into the 
LN parenchyma (Girard et al., 2012). In mesenteric LNs, the interaction of 47 integrins 
(VLA-4) with mucosal addressin cell adhesion molecule 1 (MADCAM-1) was found to play 
an important role in lymphocyte arrest (Gorfu et al., 2009). Lymphocytes crawl along the 
endothelium of HEVs until they enter the LN interstitium, whereby B cells crawl and 
transmigrate slower than T cells (Park et al., 2012). Using intravital microscopy, a recent 
study demonstrated that sialic acid regulates lymphocyte entry into LNs, as its loss affects 
the expression of L-selectin, integrins, CXCR4, CXCR5, and CCR7, thereby downregulating 
chemokine responsiveness (Zeng et al., 2020). Once transmigrated, T cells migrate into T 
cell follicles. B cells, on the other hand, remain in close proximity to HEVs for several hours, 
scanning adjacent DCs. Afterwards, B cells move along a network of stromal cells and enter 
B cell follicles, a process depending on CXCR5-CXCL13 interaction (Girard et al., 2012). If 
lymphocytes do not encounter their cognate antigen in the LN, they egress rhythmically 
through medullary lymphatic sinuses (Druzd et al., 2017; Suzuki et al., 2016), a process 
regulated by S1P signals from lymphatic ECs (Matloubian et al., 2004). Although lymphatic 
sinuses are close to HEVs, B cells do not leave the LN directly, which might be explained 
by the fact that B cells gradually retrieve the receptor for S1P (S1PR1) during their way 
through the tissue (Park et al., 2012).  
Not only lymphocytes, but also neutrophils circulate through LNs, since this cell type was 
recently detected in human and murine LNs under steady-state conditions (Lok et al., 




dependent and that their egress via efferent lymphatics is, very similar to that of 
lymphocytes, regulated by S1PR1 (Bogoslowski et al., 2018; Bogoslowski et al., 2020). 
Next to L-selectin, trafficking of this subset is dependent on CD11a, CXCR4, ICAM-1, and 
CD49d and alike other organs under circadian control, resulting in preferential homing at 
the beginning of the behavioral active phase (He et al., 2018). The molecular interactions 
during leukocyte trafficking in LNs are illustrated in Figure 1-3. 
 
1.2.5.3 Spleen 
Regarding leukocyte migration, the spleen is very similar to LNs, although it lacks HEVs 
and afferent lymphatics. The spleen receives its blood supply from the splenic artery, and 
is drained by the splenic vein, which are both emerging from the hilum. The organ 
structure is organized into the red and white pulp. Lymphocytes reside in the latter, which 
is located centrally and further divided into inner T cell zones and outer B cell follicles. B 
cell attraction to the spleen depends on endothelial CXCL13 and Clever-1 (Tadayon et al., 
2019), whereupon CXCR5-CXCL13 interactions also orchestrate their interstitial 
migration (Lewis et al., 2019). The marginal zone between the red and white pulp 
comprises B cells, macrophages and reticular cells (Mebius and Kraal, 2005). In mice, 
specialized marginal zone B cells reside in this area via interaction of LFA-1 and 47 
(LPAM) with ICAM-1 and VCAM-1 (Lewis et al., 2019). Due to open arterioles, the red pulp 
is freely accessible via the blood flow. In particular, block of CD11a and ICAM-1 impaired 
B cell extravasation from the blood into the tissue in a time-of-day-dependent manner (He 
et al., 2018). For entry of the white pulp signaling through LFA-1 and VLA-4 seems to be 
necessary (Lo et al., 2003). In contrast, other studies using blocking antibodies in 
combination with adoptive cell transfer found no role for LFA-1 in lymphocyte migration 
to the white pulp (Nolte et al., 2002).  
 
In healthy humans and mice, a large pool of neutrophils with a distinct phenotype 
(CD62Llow CD11bhigh ICAM-1high) is located close to B cells in the marginal zone, aiding in 
their activation (Puga et al., 2011). In addition, aged neutrophils migrate to the spleen, 
which are removed from the circulation under physiological conditions (Hyun and Hong, 
2017). Moreover, L-selectin was found to be required for rhythmic homing of neutrophils 
and B cells to the spleen (He et al., 2018), whereas the egress of both cell types is 
dependent on S1P-S1PR1 interaction (Blaho and Hla, 2014). Together with the LN, 






Figure 1-3: Leukocyte trafficking in the lymph node and spleen. 
In the LN, some lymphocytes enter through afferent lymphatics, guided by CCR7-CCL19/CCL21 
interaction. However, naïve B cells enter through HEVs in a sequential process of interaction of 
CD62L and PNAd, followed by activation of CCR7 via its ligands CCL19/CCL21 and LFA-1 with 
ICAM-1. Transmigrated B cells enter B follicles guided by CXCR5-CXCL13 interaction. B cells leave 
the LN via S1P-S1PR1 binding, as S1P levels are higher in efferent lymphatics. This process is 
opposed by CXCR4 and CCR7. Neutrophils circulate through the LN as well, for which they require 
CD62L and S1PR1. In the spleen, leukocytes enter the red pulp through blood sinusoids, mediated 
by LFA-1 interactions with endothelial ICAM-1. From the red pulp, B cells migrate to the white pulp, 
which probably requires integrin signaling. In the B cell follicle, B cells migrate via CXCR5-CXCL13 
interaction. Marginal zone B cells are captured via integrin binding to endothelial ICAM-1 and 







Besides its metabolic function, the liver constantly encounters antigens from the intestinal 
tract as it receives the majority of its blood supply from the mesenteric venous circulation. 
Additionally, systemic antigens reach the liver via the arterial circulation. Hence, to 
maintain homeostasis the liver contains immune cells including myeloid-derived DCs and 
Kupffer cells (tissue resident macrophages), as well as conventional (CD4+ and CD8+ T 
cells, B cells, NK cells) and unconventional (NKT cells,  TCR+ T cells, CD4-CD8- T cells) 
lymphocytes (Nemeth et al., 2009). On the contrary, neutrophils are mostly absent and 
have to immigrate (Gregory et al., 1996). The large hepatic blood vessels terminate in 
capillaries lined by fenestrated liver sinusoidal ECs (LSECs) (Wisse, 1972), a cell type 
important for antigen presentation and interaction with leukocytes. Under homeostatic 
conditions, LSECs were found to express a different set of adhesion molecules than post-
capillary venules, with very low expression of VCAM-1 and E/P-selectins, whereas VAP-1 
and ICAM-1 are constitutively expressed (Steinhoff et al., 1993). However, it was shown 
that VCAM-1 expression increases in mice over the day and is involved in rhythmic 
neutrophil recruitment to the liver at night (He et al., 2018). These adhesion molecules 
interact with 2-integrins expressed on leukocytes, whereby LFA-1 binds with lower 
affinity than Mac-1 (Tong et al., 2018). Another difference between venules and sinusoids 
is that leukocyte rolling along sinusoidal endothelium does not require selectins. It was 
thought that physical trapping of neutrophils alone regulates adhesion in the liver (Wong 
et al., 1997). However, CD44 could be identified as crucial molecule in neutrophil 
recruitment following challenge with lipopolysaccharide (LPS). Absence or block of CD44 
resulted in reduced neutrophil adhesion in sinusoids and inhibition of the CD44/HA 
interaction diminished neutrophil entry into the liver parenchyma (McDonald et al., 
2008). A study from 2009 identified ESAM, a nonclassical member of the JAM family, as 
important molecule for hepatic neutrophil transmigration in ischemia-reperfusion, 
whereas it was not mediating the transmigration of T cells in this injury context 
(Khandoga et al., 2009).   
Regarding lymphocytes, increasing evidence indicates that selective integrin-dependent 
and -independent recruitment mechanisms to the liver exist under steady-state and 
inflammatory conditions. Whereas 2-integrins mediate leukocyte adhesion in post-
sinusoidal venules (Li et al., 2004), the majority of leukocytes located in sinusoids does 
not require the activation of these adhesion molecules, as TNF-induced adhesion was 
not affected by the absence of their ligand ICAM-1 (Patrick et al., 2007). As mentioned 




adhesion and transmigration of lymphocytes under physiological shear stress (Lalor et al., 
2002). In contrast, murine hepatic ECs express only little amounts of VAP-1 under steady 
state, but upregulate expression under inflammatory conditions (Bonder et al., 2005). 
Important for hepatic immune cell trafficking is the chemokine receptor CXCR3 and its 
ligands CXCL9, CXCL10 and CXCL11. However, their function seems to be redundant, since 
block of individual molecules only partially affected leukocyte migration (Curbishley et 
al., 2005). Infiltrating lymphocytes bind VCAM-1 on hepatic ECs via CXCL16 mediated 
integrin activation (Heydtmann et al., 2005). In contrast, blocking of the VCAM-1 binding 
partner VLA-4 led to increased B cell numbers in the liver (He et al., 2018). Similar to the 
LN, B cell homing to the liver was affected in mice deficient for Cosmc, an endoplasmatic 
molecular chaperone that is required for successful formation of extended O-glycans 
(Zeng et al., 2020). Summarized, leukocyte trafficking in the liver is highly dependent on 
the anatomical location as well as the stimulus, although underlying processes are not 






Figure 1-4: Leukocyte trafficking to the liver. 
Leukocyte trafficking takes place in sinusoids, which are lined by a fenestrated layer of liver 
sinusoidal endothelial cells (LSECs). Neutrophils interact with these cells via integrins, which bind 
to ICAM-1 and VCAM-1. Moreover, CD44 binding to hyaluronic acid (HA) facilitates neutrophil 
migration in the liver. B cells can interact with LSECs via covalent bonds generated by VAP-1, which 
is highly expressed in the human liver. Their adhesion is mediated by integrin binding to ICAM-1 
and VCAM-1 and regulated by the chemokine CXCL16. B cell transmigration into the tissue requires 
CXCR3 binding to its ligands CXCL9, CXCL10 and CXCL11. 
 
1.2.5.5 Lung 
The lung is constantly exposed to airborne pathogens and thus has to assure an effective 
host defense. Similar to the liver, it receives blood from two circulatory pathways, one 
transporting oxygen under high pressure to the bronchial tree, the other responsible for 
gas exchange under low pressure (Aird, 2007). The alveolus represents the smallest 
functional unit and is separated by a thin membrane from a vast network of capillaries. In 
comparison to systemic circulation, the majority of leukocyte trafficking does not occur in 
post-capillary venules but in these pulmonary capillaries, which exhibit a continuous EC 
layer. Under steady-state conditions, their vascular bed harbors a large pool of leukocytes, 




Due to the fact that the diameter of capillaries (2-14 µm) is smaller than that of a 
neutrophil (13.7 µm) and most other leukocyte subsets, leukocytes cannot roll along the 
endothelium, but have to deform to search for a suitable transmigration site (Doerschuk 
et al., 1993). In combination with the low blood flow prolonging the time of transit as well 
as CXCR4-CXCL12 interactions (Devi et al., 2013), neutrophils are highly enriched in the 
lung, called ‘marginated pool’ (Wiggs et al., 1994), from which they can detach quickly in 
response to an inflammatory challenge (Yipp et al., 2017). In addition, a recent study 
showed that after sterile liver injury, neutrophils reenter the circulation from the liver and 
migrate to marginated pools in the lung, where they increase expression of CXCR4 and 
home back to the BM for clearance (Wang et al., 2017). B cell recruitment to the lung under 
steady state can be blocked by inhibition of ICAM-1, CXCR4, CD49d, and CD11a (He et al., 
2018).  
In general, and in contrast to the steady state, leukocyte recruitment to the lung differs 
between various disease models. Mechanisms can involve L- and E-selectin, e.g. during an 
LPS challenge, but they have also been shown to be 2-integrin-independent, e.g. in a lung 
injury followed by Escherichia coli administration (Maas et al., 2018), suggesting a 
compensatory mechanism. Classical adhesion molecules for leukocyte capture are not 
involved in lung recruitment, but once neutrophils are in contact with the stimulated 
endothelium, L-selectin and integrins are necessary to hold the cells inside the capillaries 
(Kubo et al., 1999). Furthermore, a critical role for ICAM-1 and LFA-1 for neutrophil 
recruitment during LPS-induced inflammation was demonstrated using mice deficient for 
these molecules (Basit et al., 2006). Monocytes are recruited to the lung in a CCR2-
dependent manner, whereas neutrophils intravasate independently of CCR2. However, 
CCR2+ monocytes were found to augment a neutrophil accumulation (Maus et al., 2003). 
In mice, endothelial and leukocyte-expressed CXCR2 is the most important chemokine 
receptor mediating LPS-induced neutrophil recruitment (Reutershan et al., 2006; Strieter 







Figure 1-5: Leukocyte trafficking in the lung. 
Due to the constricted vessel size of sinusoids, neutrophils have to deform and crawl through the 
vessel, mediated by CXCR4 and CXCL12. To reside in the pulmonary vasculature, the adhesion 
molecules CD62L, LFA-1 and Mac-1 are important. Lymphocytes require this receptor-ligand-axis 
as well and interact with lung endothelial cells via integrin binding to ICAM-1.  
 
Combined, these data illustrate the intricacy of leukocyte trafficking to various organs. 
Besides immune cell type-specificity, anatomical properties of the respective organ play 
an important role. To add another level of complexity, the tissue microenvironment is 
under influence of the sympathetic nervous system. In the next section, features of the 
sympathetic nervous system, as well as its innervation of the investigated organs is 







1.3 The sympathetic nervous system 
 
Similar to the immune system, the nervous system comprises a complex network of 
various cell types interacting with each other as well as numerous other components in 
the body. The nervous system of vertebrates is classified into the central nervous system 
(CNS) and the peripheral nervous system, which further subdivides into the somatic, 
sensory and autonomic nervous system. The autonomic nervous system is not under 
conscious control and consists of the interconnected sympathetic (SNS) and 
parasympathetic nervous system (PNS). The SNS emerges from the thoracolumbar spinal 
cord and is responsible for the so-called “fight-or-flight” response by controlling the 
activation of cardio-vascular organs. Its counterpart, the PNS, is derived from the cranial 
nerves and the sacral spinal cord and drives digestive processes during the resting state. 
The SNS consists of preganglionic neurons acting via acetylcholine (ACh) on 
postganglionic neurons, which innervate peripheral target tissues such as lymphoid 
organs (Bellinger et al., 2008; Felten et al., 1987; Nance and Sanders, 2007).  
 
1.3.1 Catecholamines  
From its nerve varicosities the SNS mainly releases the catecholamine norepinephrine 
(noradrenaline, NE) with the exception of some cholinergic sympathetic nerves releasing 
ACh (Zeisel et al., 2018) or dopamine, such as in sweat glands and the periosteum 
(Apostolova and Dechant, 2009). Additionally, the SNS innervates the adrenal gland, thus 
triggering the systemic release of epinephrine (adrenaline, EPI) and glucocorticoids into 
the blood. Catecholamines contain a catechol or 3,4-dihydroxyphenyl group as well as a 
side chain amine and act in the body as hormones and neurotransmitters. The synthesis 
of NE starts with the transformation of the amino acid tyrosine into levodopa through 
tyrosine hydroxylase (TH). Levodopa is decarboxylated into dopamine by DOPA 
decarboxylase. NE is synthesized from dopamine by dopamine -hydroxylase and can be 
converted to EPI by phenylethanolamine N-methyltransferases in the adrenal medulla 
(Kuhar et al., 1999). Production and release of these catecholamines into the blood stream 
follows a time-of-day-dependent rhythm, which is reciprocal in mice and humans (De 
Boer and Van der Gugten, 1987; Linsell et al., 1985; Sauerbier and von Mayersbach, 1977). 
However, conditions of these rhythms differ between NE and EPI. Whereas EPI exhibits 




such as food uptake, and thus cannot be termed truly circadian (Leach and Suzuki, 2020; 
Stanley et al., 1989). 
Moreover, their levels differ between tissues as well as between tissue compartments, as 
shown for LNs (Felten et al., 1985) and although EPI and NE bind to the same receptors, 
EPI shows a higher affinity for e.g. 2-adrenoceptors than NE (Liapakis et al., 2004). 
These neurohormones influence multiple activities in the body as rapid responses to 
environmental changes, such as blood pressure increase and bronchial relaxation, which 
are part of the “fight-or-flight” response. Thus, these mechanisms are considered as 
prerequisite for survival. However, prolonged increase of catecholamines can lead to 
pathological conditions, like hypertension and heart failure (Tank and Wong, 2015).  
 
1.3.2 Adrenergic receptors 
The cell surface receptors to which catecholamines bind are called adrenergic receptors 
(AR). ARs belong to the guanine nucleotide-binding GPCR superfamily of seven-
transmembrane proteins. The GPCRs are classified into 1- - and -ARs, which can be 
further subdivided into 1A-, 1B-, 1C-, 2A-, 2B-, 2C-, as well as 1-, 2-, and 3-ARs. 
Depending on the interconnected G protein of the receptor, different signaling pathways 
can be initiated upon ligand binding. The heterotrimeric G protein complex consists of 
an  subunit, which can be stimulatory (Gs), inhibitory (Gi) or activate phospholipase C 
enzymes (Gq), and a  complex (Pierce et al., 2002). 1 is Gq-coupled, 2 is Gi-coupled, and 
-ARs are predominantly Gs-coupled, but can switch to Gi (Figure 1-7). GPCRs exhibit 
diverging affinities for different catecholamines and vary in expression levels on target 
cells. Since -ARs are the predominant receptor type expressed on leukocytes (Elenkov et 
al., 2000), they were used as targets for pharmacological modulation in this study. 
The first member of the -AR family is the predominant receptor in the heart, where it 
regulates myocardial contractility. Thus, antagonists of the 1-AR are commonly used as 
therapeutics for cardiovascular diseases like hypertension. In humans, it is also expressed 
in the kidney and fat cells, regulating renin release and lipolysis, respectively (Alhayek 
and Preiss, updated 2020 Aug 11).  
The 2-AR was the first GPCR to be cloned (Dixon et al., 1986) and characterized based on 
its physiological properties. It was thought to predominantly inhibit the immune system 
via cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA). Importantly, to 
current knowledge signaling pathways of this receptor subtype are much more complex. 




2-ARs are expressed by every immune cell type, exhibiting varying expression levels, 
which could explain a differential cell responsiveness to adrenergic stimuli. NK cells show 
the highest number of receptors per cell, B cells and monocytes have intermediate 
numbers and T helper (Th) cells show the lowest numbers of receptors on their surface 
(Elenkov et al., 2000). Eosinophils express about 7,166 receptors per cell (Yukawa et al., 
1990) and on neutrophils receptor binding assays revealed approximately 900 receptors 
(Galant and Allred, 1981). Interestingly, Th1 cells express 2-ARs, whereas Th2 cells do 
not (Sanders et al., 1997). Expression levels also vary during maturation and aging 
(Radojcic et al., 1991). Furthermore, responsiveness to stimuli does not necessarily 
depend on receptor density, as coupling of GPCRs and adenylyl cyclase (AC) plays a role 
as well (Maisel et al., 1989). 
The human Adrb3 gene was first cloned in 1989 (Emorine et al., 1989). Since then, it was 
identified in several other species like mouse, where two tissue-specific splice variants 
were characterized (Evans et al., 1999). In comparison to the other two subtypes, the 3-
AR lacks the phosphorylation sites for PKA and -AR kinase (ARK), protecting it from 
desensitization (Nantel et al., 1993), whereas a similar process can occur downstream in 
the signaling cascade by reduction of AC function (Michel-Reher and Michel, 2013). 
However, data in this regard are not always consistent and have to be interpreted 
carefully (Okeke et al., 2019). The human 3-AR has been detected in blood vessels, brain, 
urinary bladder, adipose tissue, myocardium, and several other tissues (Schena and 
Caplan, 2019). The murine receptor is most abundant in white and brown adipose tissue 
where it mediates thermogenesis and lipolysis (Nahmias et al., 1991), but is also 
expressed by stromal cells in the BM (Mendez-Ferrer et al., 2008). Mice lacking 3-ARs 
show a modest increase in fat stores with females being more affected than males. 
Furthermore, Adrb1 mRNA is upregulated in adipose tissues of these mice, suggesting a 
crosstalk between these receptor subtypes (Susulic et al., 1995).  
 
1.3.3 Sympathomimetic/sympatholytic agents 
Due to the crucial role of catecholamines in diverse physiological processes, drugs for 
clinical use have been developed. These drugs are classified as sympathomimetic when 
mimicking the action of catecholamines, and as sympatholytic when blocking the binding 
of catecholamines to their receptors. These reagents can be administered via various 
routes and are able to act directly by binding to the respective ARs, or indirectly by 




(SABA) like Salbutamol are used for resolution of acute bronchoconstriction and are 
therefore the frontline therapy of asthma. They start acting within a few minutes and last 
for about four to six hours. Long acting -AR agonists (LABA) like Salmeterol and 
Formoterol are used as first treatment of chronic obstructive pulmonary disease (COPD). 
Maintenance treatment of patients with COPD requires ultra-long acting -AR agonists 
(Ultra-LABA) like Indacaterol. It is rapidly absorbed and functions for about 24 hours 
(Billington et al., 2017).  
Sympathomimetic and sympatholytic agents can either target the whole family of 
receptors, like the pan--AR agonist Isoproterenol and the pan--AR antagonist 
Propranolol, or they can exhibit selectivity for distinct subtypes.  
Denopamine is a selective agonist of 1-ARs and exhibits, like all agonists, dose-dependent 
effects (Masanori et al., 1987). As selective 2-AR agonist, long-acting Clenbuterol was 
used in this study (Hall et al., 1980). It shows similar properties as Salbutamol and is 
utilized as bronchodilator in diseases like asthma (Al-Majed et al., 2017b). Several 3-AR 
agonists have been tested in clinical trials, such as Mirabegron for treatment of overactive 
bladder syndrome (Takasu et al., 2007). In this thesis, the 3-AR agonist BRL37344 was 
used, which belongs to the first-generation compounds and was developed in 1990. It 
displays a higher affinity and potency for rodent over human receptors (Nahmias et al., 
1991). Although it shows higher selectivity for 3- compared to 1- and 2-ARs, evidence 
exists that also other ARs are stimulated by this agonist (Mori et al., 2010; Pott et al., 
2003).  
 
1.3.4 Adrenergic signaling pathways 
To understand how adrenergic signaling influences immune cell trafficking, it is important 
to understand the different molecular mechanisms that can be triggered by stimulation of 
-ARs (Figure 1-6). Attachment of an agonist to the -AR leads to its conformational 
change facilitating the binding of the Gs heterotrimer (consisting of ,  and  subunits) to 
the receptor. Subsequently, guanosine diphosphate (GDP) in the -subunit is replaced by 
guanosine triphosphate (GTP), resulting in the dissociation of the - and -subunits from 
the GPCR. After recruitment of the -subunit to the membrane-associated lipid raft, it 
activates AC, whereas the -subunit regulates Ca2+ channels. AC facilitates the hydrolysis 
of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). PKA is 
activated by binding of cAMP to its regulatory subunit and subsequent release of the 
catalytic subunit. With the help of A-kinase anchor proteins (AKAPs), PKA is localized in 




membrane and the other remains intracellular where it mediates gene transcription 
(Lorton and Bellinger, 2015). Afterwards, different mechanisms can lead to a 
downregulation of cAMP levels (Vandamme et al., 2012) and the Gs heterotrimer 
reassembles by conversion of GTP back to GDP (Rasmussen et al., 2011).  
-AR concentrations on cell surfaces are dynamically regulated by neurotransmitter 
concentrations. In a multistep process, high levels lead to a decreased responsiveness and 
following downregulation, which results from GPCR phosphorylation by GRKs (Choi et al., 




Figure 1-6: Activation and regulation of -ARs. 
After binding of catecholamines to -ARs the heterotrimeric G protein is recruited to the receptor 
(step not shown). When GDP on the (s) subunit is converted to GTP, the G protein dissociates. 
While the -subunit regulates Ca2+ channels, the (s)-subunit relocates to the lipid raft, where it 
activates adenylyl cyclase (AC). This enzyme catalyzes the conversion from ATP to cAMP, which 
activates the protein kinase A (PKA). This enzyme is responsible for GPCR-regulated changes in 
gene expression. If the heterotrimeric G protein consists of an inhibitory -subunit ((i)), the 
activity of AC is blocked. To regulate the signaling through -ARs, G protein-coupled receptor 
kinases (GRKs) phosphorylate the receptor, to which -arrestin binds, leading to receptor 
internalization. 
 
Extensive investigation of the 2-AR revealed alternative routes without AC and cAMP 




regulated by Gs, GPCR phosphorylation by PKA decreases the binding affinity for Gs, 
resulting in a switch from Gs to Gi (Daaka et al., 1997). This pathway leads to the activation 
of extracellular signal-regulated kinase (ERK) via the -subunit. In addition, the -
subunit was shown to activate ERK in a cascade involving the non-receptor tyrosine 
kinase c-Src and the G protein Rat Sarcomer (Ras) (Daaka et al., 1997). Other more recent 
studies also demonstrated a mechanism independent of G proteins (Shenoy et al., 2006) 
and evidence for a -arrestin independent pathway of ERK activation via 2-AR signaling 
(O’Hayre et al., 2017). In HEK-293 cells, activation of this AR subtype led to intracellular 
Ca2+ flux via activation of phospholipase C (PLC) and inositol triphosphate (IP3), 
independently of cAMP (Galaz-Montoya et al., 2017).  
 
 
Figure 1-7: G protein switch and non-canonical signaling. 
When protein kinase A (PKA) phosphorylates -ARs, the affinity for (s) is reduced, while the 
affinity for (i) is increased, leading to a switch of G proteins associated with the receptor. During 
non-canonical signaling, the -subunit activates the extracellular signal-regulated kinase (ERK) 
via SRC and Ras activation. Meanwhile, the (i)-subunit activates AC, resulting in higher cAMP 
levels. This second messenger activates PKA, which in turn activates other molecules in the 





1.3.5 Sympathetic innervation of peripheral organs 
As in this thesis the influence of adrenergic stimulation on leukocyte trafficking in selected 
organs was investigated, it is necessary to understand how these tissues are innervated 
by the SNS. In the following, sympathetic innervation of the BM, LNs, spleen, liver, and 
lung are described. 
 
1.3.5.1 Bone marrow 
To reach the BM, efferent sympathetic nerves enter small tunnels of the cortex (nutrient 
foramina) of long bones and run along the vasculature in microscopic channels of the 
cortical bone (Haversian and Volkmann´s canals) (Calvo, 1968). There, nerves positive for 
TH, the rate limiting enzyme in NE production, are more abundant than nerves containing 
neuropeptide Y and vasoactive intestinal peptide (Tabarowski et al., 1996). The BM 
vasculature consists of evenly distributed sinusoids and arterioles, thus bringing SNS 
varicosities in close proximity to immune cells. Previous studies showed that adrenergic 
signals regulate bone formation (Takeda et al., 2002) and HSC release from the BM 
(Katayama et al., 2006), the latter in a rhythmic manner (Mendez-Ferrer et al., 2008; 
Scheiermann et al., 2012). 
 
1.3.5.2 Lymph nodes 
In LNs adrenergic fibers enter at the hilar region along with blood vessels, distributing 
into a subcapsular nerve plexus or into the medulla through the medullary cords (Felten 
et al., 1984). Sympathetic nerve fibers in rodents surround germinal centers and extend 
into paracortical and cortical regions, where they end among lymphocytes (Felten et al., 
1985). The innervation of human LNs is similar, which is mostly associated with blood 
vessels (Panuncio et al., 2002). 
 
1.3.5.3 Spleen 
Sympathetic nerve fibers arising from the celiac-mesenteric ganglia enter the spleen at 
the hilum together with the splenic artery (Felten et al., 1987). In close proximity to the 
vasculature, they continue along the trabeculae into the trabecular plexuses (Williams and 
Felten, 1981). A dense nerve fiber network was found in multiple splenic compartments, 
including the periarteriolar lymphatic sheath (containing T cells), the marginal zones, the 




differentiation and maturation in the splenic nodules as well as antigen presentation in 
the marginal zones is regulated by adrenergic innervation (Hu et al., 2020). Importantly, 
the microanatomy of rodent spleens differs from the one of human spleens, as e.g. the 
marginal zone is missing in humans (Steiniger, 2015). Furthermore, sympathetic 
innervation in murine spleens changes in the course of aging, since catecholamine-
containing fibers as well as NE levels increase with rising age (Madden et al., 1997). 
 
1.3.5.4 Liver 
The sympathetic branch innervating the liver originates in the celiac and superior 
mesenteric ganglia receiving pre-ganglionic neurons from the intermediolateral column 
of the spinal cord (Yi et al., 2010). Nerve distribution differs between species, but in 
general sympathetic markers were detected in the hepatic artery, the portal vein region 
and in the area around bile ducts. In comparison to the human liver, rodent nerve fibers 
do not reach parenchymal cells (Fukuda et al., 1996). Nonetheless, this does not alter the 
parenchymal response to sympathetic innervation, probably due to the presence of cell-
cell connecting gap junctions (Seseke et al., 1992). First, only -ARs could be identified in 
the hepatic arterioles and portal vein (Green et al., 1959), but the presence of -ARs was 
demonstrated in the canine liver as well (Geumei and Mahfouz, 1968). 
 
1.3.5.5 Lung 
In the lung, sympathetic innervation mainly targets the vasculature. In contrast to other 
organs, nerve fiber density decreases from large vessels towards the periphery, but the 
density differs between species. Sympathetic and parasympathetic perivascular axons of 
rodents barely reach beyond the lung hilum, while in humans the innervation also reaches 
small vessels. The smallest intra-acinar arteries are not innervated. Pulmonary vascular 
resistance is predominantly regulated via 1-ARs. In this organ, nerve endings contain 
large and small vesicles with different neurotransmitter cocktails, which are released 
depending on the frequency of stimuli (Cifuentes et al., 2008). Hence, more than one 
transmitter is released, a phenomenon called purinergic co-transmission (Burnstock, 
2009). Airway smooth muscle cells and other cell types in the lung, like immune cells 
including mast cells, macrophages and eosinophils, express 2-ARs (Barnes, 2004). Hence, 
in humans, the lung is a common target for 2-AR agonists to treat airway diseases like 




1.4 Neuro-immune crosstalk 
 
To maintain homeostasis as well as fight pathogens, cross-talk between the immune 
system and the nervous system is essential. Two regulatory pathways are responsible for 
signal transduction, the hypothalamic-pituitary-adrenal axis (HPA) and the SNS. The 
latter communicates with immune cells via synaptic varicosities releasing NE or by the 
systemic adrenal hormone EPI, which are both recognized by ARs expressed on a variety 
of cell types in target organs. Under homeostatic conditions the SNS leads to recovery after 
an injury or immune challenge, which involves the regulation of cell differentiation, 
expansion and effector functions (Lorton and Bellinger, 2015; Nance and Sanders, 2007). 
Observed effects of catecholamines on various aspects of immunity depend on the 
microenvironmental and inflammatory context as well as catecholamine levels. Moreover, 
catecholamines can affect leukocyte function and migration on multiple levels, controlling 
mechanical cell properties, cytokine release, and expression of adhesion molecules. 
Importantly, these catecholamines do not necessarily have to originate from nerve 
endings since they can also be produced and released by immune cells like macrophages 
(Flierl et al., 2007) or T cells (Rosas-Ballina et al., 2011). Stimulation of 2-ARs has various 
effects on immune cell function, such as inhibition of NET formation (Marino et al., 2018). 
In vitro treatment of neutrophils with NE also impaired neutrophil chemotaxis, 
phagocytosis, and activation via suppressed production of IFN and IL-10 (Nicholls et al., 
2018). In this study, the influence of adrenergic stimulation – in particular -AR 
stimulation – on leukocyte trafficking was investigated. Hence, a short summary of the 
current knowledge about the complex effects of adrenergic signals on leukocyte 
mobilization and recruitment to tissues is given.  
 
1.4.1 Leukocyte trafficking under adrenergic control 
The life time of many immune cells in the body is severely limited, thus their numbers 
have to be regularly replenished to maintain homeostasis. Cells capable of self-renewal, 
proliferation and differentiation, called HSCs, and partially lineage-committed HSPCs, 
leave their niches in the BM and circulate through blood and lymph to reach peripheral 
tissues (Massberg et al., 2007). Under steady-state conditions in mice, egress of HSPCs 
from the BM is regulated by catecholamines targeting 3-ARs on stromal cells, leading to 
a downregulation of the retention factor CXCL12 (Mendez-Ferrer et al., 2008). 




or block of sympathetic signaling reduced G-CSF-dependent HSPC mobilization 
(Katayama et al., 2006). On the other hand, circadian oscillations in adhesion to the BM 
vasculature are abolished upon loss of local innervation due to a leveled rhythmic 
expression pattern of endothelial ICAM-1 (Scheiermann et al., 2012). Using adoptive 
transfers of wild-type (WT) cells into mice lacking 2- or 3-ARs, this study also 
demonstrated the influence of both -ARs on this process, since mice deficient for each 
receptor type exhibited reduced oscillations in recruitment as well as no circadian 
differences in adhesion molecule expression. A recent study unraveled the paradox of 
mobilization and homing being regulated by the same signals in a time-of-day-dependent 
context. They showed that during the day, the cholinergic neurotransmitter ACh inhibits 
adhesion, while noradrenergic signals facilitate cell mobilization via 3-ARs. At night, 
higher levels of EPI stimulate 2-ARs while cholinergic signals downregulate 3-AR 
expression, favoring the process of homing (Garcia-Garcia et al., 2019). Hence, adrenergic 
and cholinergic signals function counteractively to regulate circulating leukocyte 
numbers over the course of a day. 
 
In rats, short-term effects of EPI and NE administration are increased numbers of 
circulating leukocyte subsets (Dhabhar et al., 2012), suggesting an analogical mobilization 
effect for leukocytes compared to HSPCs. However, it is not clear whether rising numbers 
of circulating leukocytes are caused by adrenergic targeting of mobilization or 
demargination, the latter describing the fast detachment from vascular beds to reenter 
the circulation. Recently, it was shown for human granulocytes that in vitro incubation 
with catecholamines leads to a reorganization of cellular cortical actin, enabling 
demargination by reduction of cell stiffness (Fay et al., 2016). Interestingly, most 
leukocyte subtypes have left the circulation two hours post stimulation, whereas 
neutrophil numbers continue to increase, indicating a subtype-specific effect of 
catecholamines. Additionally, NE and EPI affect leukocyte numbers in blood in a different 
manner, as NE increases numbers of neutrophils and B cells, whereas administration of 
EPI increases numbers of neutrophils and monocytes, but decreases blood lymphocyte 
numbers (Dhabhar et al., 2012). Thus, next to the cell type-specificity of the response, also 
catecholamine-specific effects exist. 
Another level of complexity was added by a study that investigated the impact of 2-AR 
signaling on leukocyte recruitment between male and female mice. Using a dorsal skin air 




recruitment was higher in females compared to males, but that the presence of 2-ARs is 
more important for neutrophil trafficking in males than in females. Moreover, comparison 
between female and male Adrb2 deficient mice revealed different numbers of CD11a 
expressing neutrophils among recruited cells, showing higher numbers in males than 
females (de Coupade et al., 2007). Taken together, these data indicate a sexual 
dimorphism in the relationship between the sympathetic and immune system. 
Chemokines play an important role in leukocyte trafficking as these molecules activate 
immune cells leading to a firm adhesion and finally to transendothelial migration through 
blood vessels. Several studies investigated the influence of the SNS on cytokine production 
and release. Exposure of neutrophils to EPI results in dose-dependent enhanced 
production of IL-8, but a suppressed production of IL-1, IL-8, and monocyte 
chemoattractant protein 1 (MCP-1) when the treatment is combined with an LPS 
challenge. Moreover, CD11b expression on neutrophils increases under steady-state 
conditions, whereas after LPS-stimulation, CD11b and CD18 expression are suppressed 
(Margaryan et al., 2017). In contrast, another study demonstrated that stimulation with 
EPI, NE and the agonist Isoproterenol reduced N-formyl-methionyl-leucyl-phenylalanine 
(fMLP)-induced migration, CD11b/CD18 expression and ROS production, without 
influencing IL-8 expression of human polymorphonuclear cells (Scanzano et al., 2015). 
Taking these data together, catecholamines can exhibit differential effects on cytokine 
production, which seems to be dependent on the AR density on the cell surface (Wahle et 
al., 2005) as well as catecholamine dose and inflammatory context.  
SNS activation is generally believed to have immunosuppressive effects. However, this is 
dependent on several conditions such as the metabolic state, since in obese mice, 2-AR 
stimulation induced a shift towards an anti-inflammatory cytokine profile, whereas in the 
control group, pro-inflammatory cytokines prevailed (Gálvez et al., 2019). In response to 
multiple Toll-like receptor (TLR) signals, stimulation with NE blocks the secretion of pro-
inflammatory cytokines by rapid induction of IL-10 from innate immune cells (Agac et al., 
2018). Dysregulation of cytokine release can lead to a dangerously hyperactivated 
immune state, called cytokine release syndrome. How catecholamines originating from 
activated peritoneal macrophages influence these cytokine storms explored a study 
where LPS in combination with EPI produced an enhanced inflammatory response 
characterized by higher levels of IL-6, TNF and CXCL1 as well as increased mortality 




To resolve inflammation or to respond to an injury, immune cells have to enter tissues by 
diapedesis through the endothelial barrier. In a cremaster muscle model, NE nearly 
completely stalled fMLP-induced neutrophil adhesion and arrest, as well as 
transmigration (Nicholls et al., 2018). Also, retention of lymphocytes in secondary 
lymphoid organs is affected by adrenergic stimulation, leading to enhanced adaptive 
immune responses due to immune cell accumulation. In LNs, local adrenergic signaling to 
2-ARs on lymphocytes retains the cells in these secondary lymphoid organs, leading to 
reduced numbers in blood and lymph (Suzuki et al., 2016). Strikingly, the strongest 
influence of adrenergic stimulation on circulating numbers was observed for B cells, 
probably due to higher 2-AR expression on their cell surface compared to T cells. 
Adrenergic promotion of LN retention was linked to the physical interaction of the AR 
with CCR7 and CXCR4, both important chemokine receptors involved in lymphocyte 
trafficking through LNs (Nakai et al., 2014).  
Summarized, adrenergic stimulation impacts virtually every step of leukocyte trafficking. 
Observed effects highly depend on dosage of the adrenergic agonist and its time of 
exposure, the inflammatory milieu, metabolic state and gender of the host, as well as the 
target cell type and tissue (Figure 1-8). This high level of complexity makes it more 
difficult to get an overview of the adrenergic influence on leukocyte trafficking. 
Furthermore, the interconnection of the sympathetic and the immune system was often 
studied in an inflammatory context, while knowledge about processes under steady-state 







Figure 1-8: Adrenergic control of leukocyte trafficking. 
Adrenergic signaling has multiple effects. (A) In cooperation with cholinergic signals, it regulates 
the circadian egress of hematopoietic stem and progenitor cells (HSPCs) from and homing of 
leukocytes to the BM (García-García et al., 2019; Mendez-Ferrer et al., 2008; Scheiermann et al., 
2012). (B) Stimulation with NE and EPI leads to changes of the blood leukocyte subset composition 
in rats (Dhabhar et al., 2012). (C) Exposure of neutrophils to EPI was shown to alter their 
expression profile depending on the inflammatory context (Margaryan et al., 2017; Scanzano et al., 
2015). (D) NE blocks the migration of neutrophils in a cremaster model (Nicholls et al., 2018). (E) 
Activation of 2-ARs on lymphocytes was shown to cause their retention in LNs, mediated by 
interactions of -ARs with chemokine receptors (Nakai et al., 2014; Suzuki et al., 2016). (F) The 
metabolic state plays a role in the interplay, as in obese mice 2-AR stimulation leads to an anti-
inflammatory cytokine profile, compared to wild-type mice, which were shown to exhibit a pro-
inflammatory cytokine profile (Gálvez et al., 2019). (G) Gender was demonstrated to influence 
adrenergic leukocyte trafficking, since neutrophil recruitment to a dorsal air pouch was higher in 
females, while 2-ARs played a more dominant role in males. Additionally, numbers of CD11a+ cells 





1.5 Aim of the study 
 
Since every living organism encounters stress, it is important to be aware of its effects on 
the immune system. For proper functioning, immune cells have to migrate through the 
body and enter target tissues, a process called leukocyte trafficking. The aim of this thesis 
was to investigate this process specifically for representative of the innate and adaptive 
arm of immunity – neutrophils and B cells, respectively – upon modulation of adrenergic 
signaling in several organs. To achieve this, -ARs of WT mice were pharmacologically 
stimulated and the distribution of these leukocyte subsets between blood, BM, LNs, liver, 
lung, and spleen was determined using flow cytometry. Using intravital microscopy of the 
popliteal LN, their migratory behavior was investigated in more detail. To unravel the role 
of specific -ARs, genetically modified mouse strains lacking 2- or 3-ARs were examined 















Seven-weeks old C57BL/6N or J WT mice of both genders were purchased from Janvier 
Labs (Le Genest-Saint-Isle, France) or Charles River Laboratories (Sulzfeld, Germany) and 
used for experiments at an age of eight to nine weeks. Adrb2-/- (Adrb2 KO) and Adrb3-/- 
(Adrb3 KO) mice were kindly provided from Gerard Karsenty (Columbia University, NYC, 
USA) and Paul Frenette (Albert Einstein College of Medicine, NYC, USA). Mice were housed 
under a 12hr:12hr light-dark cycle with food and water ad libitum. All animal 
experimental procedures were performed in accordance with the German Law of Animal 
Welfare and approved by the Regierung von Oberbayern. 
2.1.2 Genotyping 
Biopsies obtained from ears were digested at 55°C overnight in 200 µl digestion buffer 
(Table 2-14) supplemented with 1 µl proteinase K (1.5 U/sample). The following day, 
samples were centrifuged at 18,000 x g and room temperature for 10 min and the 
supernatant was transferred to a new tube containing 500 µl isopropanol. Precipitated 
DNA samples were centrifuged at 18,000 x g and room temperature for 10 min and the 
supernatant was removed. Pellets were dissolved in 100 µl TE buffer (Table 2-14) for 1 h 
at 37°C and either used directly for polymerase chain reaction (PCR) or stored at -20°C. 
For genotyping PCR, 1 µl of extracted DNA solution was mixed with 8.6 µl nuclease-free 
water, 10 µl 2x FastGene master mix and 0.5 µl of each, forward and reverse primer (10 
µM, Table 2-1). DNA was amplified according to protocols in Table 2-2 on a Mastercycler 
Epgradient S (Eppendorf). 10 µl of the PCR product were applied on a 1% agarose gel 
supplemented with Midori Green (1:25,000, Nippon Genetics). All samples were run for 
30 min at 120 V together with the FastGene 100 bp DNA Marker (Nippon Genetics). The 







All primer sequences were kindly provided by Paul Frenette and purchased at Eurofins 
(Munich, Germany). Adrb= -adrenoceptor, WT= wild type, KO = knockout. 
 
Table 2-1: Primers and respective sequences. 
Primer Sequence (5´→ 3´) 
Adrb2 forward AGG GGC ACG TAG AAA GAC AC 
Adrb2 WT reverse ACC AAG AAT AAG GCC CGA GT 
Adrb2 KO reverse GAG ACT AGT GAG ACG TGC TAC T 
Adrb3 WT forward GTT GCG AAC TGT GGA CGT CAG TGG 
Adrb3 KO forward GCG ATC GCC TTC TAT CGC CTT CTT G 
Adrb3 reverse AAT GCC GTT GGC GCT TAG CCA C 
 
 
2.1.4 PCR protocols 
Table 2-2: PCR protocols. 
Gene Step Temperature Time Cycles Product 
Adrb2-/- 





Denaturation 94°C 30 sec 
35x Annealing 55°C 40 sec 
Extension 72°C 1 min 
Final extension 72°C 10 min 1x 
      
Adrb3-/- 





Denaturation 94°C 30 sec 
35x Annealing 63°C 40 sec 
Extension 72°C 1 min 









2.1.5 Pharmacological adrenergic stimulation and blockade 
Two hours prior to blood and organ harvest (10 am or 6 pm), mice were injected 
intraperitoneally with either 100 µl PBS or 5 mg/kg Isoproterenol (pan--AR agonist, 
Sigma-Aldrich), 5 mg/kg Propranolol (pan--AR antagonist, Sigma-Aldrich), 2 mg/kg 
Clenbuterol (2-AR agonist, Sigma-Aldrich) or 2 mg/kg BRL37344 (3-AR agonist, Sigma-
Aldrich) in PBS. 14 µg/kg Denopamine (1-AR agonist, Sigma-Aldrich) were dissolved in 
9% DMSO in PBS, which was used as control for this specific agonist.  
 
2.1.6 Chemical sympathectomy 
For complete sympathetic ablation in the periphery, mice were injected intraperitoneally 
with 100 mg/kg of 6-hydroxydopamine (6-OHDA, with 20 mg/ml ascorbate in saline) on 
day 0 and 250 mg/kg on day 2 and analyzed from day 5 on.   
 
2.1.7 Induction of inflammation 
To investigate the influence of adrenergic stimulation on circulating leukocyte numbers 
under inflammatory conditions, mice were intraperitoneally injected with 0.5 µg TNF, 
one hour prior to injection of adrenergic agonists and three hours prior to blood harvest 
at 12 pm or 8 pm.  
 
2.1.8 Organ harvest and processing for flow cytometry 
2.1.8.1 Blood 
During adoptive transfer experiments, blood from anaesthetized mice was collected retro-
orbitally into EDTA-coated microhematocrit tubes (VWR). Collecting tubes contained 5 µl 
EDTA (5 mM) to prevent clotting. For experiments without subsequent perfusion, blood 
from euthanized mice was harvested from the Inferior Vena Cava using a syringe 
equipped with a 20G-needle containing 50 µl EDTA (5 mM). Samples were counted using 
a ProCyte Dx® cell counter (IDEXX Laboratories). Erythrocytes were lysed by incubation 
in 5 ml RBC lysis buffer (Table 2-14) for 5 min, once at room temperature and once on 
ice. The lysis was stopped with an equal amount of PBS and cells were centrifuged at 




transferred to 5 ml polystyrene tubes or in 200 µl PEB and transferred to wells of a 96-
well V-bottom plate for centrifugation and subsequent staining. 
2.1.8.2 Bone marrow 
To obtain donor cells for investigation of myeloid cell trafficking, both femora and tibiae 
were harvested, cleaned and flushed with 1 ml PBS. Cell clusters were disaggregated by 
pipetting. To investigate cell numbers in the BM of recipients, only one femur was used. 
Erythrocytes were lysed by incubation in 4 ml RBC lysis buffer (Table 2-14) for 5 min at 
room temperature. The lysis was stopped with an equal amount of PBS and samples were 
centrifuged at 300 x g and 22°C for 5 min. Cell pellets were resuspended in 1 ml PEB 
(Table 2-14) and 300 µl were transferred to 5 ml polystyrene tubes or 100 µl to wells of 
a 96-well V-bottom plate for centrifugation and subsequent staining. 
2.1.8.3 Lymph nodes 
To obtain donor cells for investigation of lymphocyte trafficking, both popliteal, inguinal, 
axillary, brachial, superficial parotid and lumbar lymph nodes, as well as one mesenteric 
lymph node were harvested. From recipients, eight skin-draining lymph nodes (popliteal, 
inguinal, axillary and brachial) and one gut-draining lymph node (mesenteric) were 
harvested. Lymph nodes were processed through a 40 µm cell strainer and centrifuged at 
300 x g and 22°C for 5 min. Cell pellets were resuspended in 1 ml PEB (Table 2-14) and 
100 µl were transferred to 5 ml polystyrene tubes. For analysis in a 96-well V-bottom 
plate, 500 µl of the pooled skin-draining lymph nodes and the whole sample of the gut-
draining lymph node were transferred to each well. Samples were then centrifuged and 
stained.  
2.1.8.4 Liver 
The median lobe of the perfused liver was harvested into DPBS (Life Technologies). For 
extrapolation to the whole organ the rest of the liver was harvested into an empty 
collection tube and the weight of both parts was measured. The median lobe was cut into 
pieces and incubated with 1 mg/ml collagenase IV (C5138, Sigma-Aldrich) and 0.2 mg/ml 
DNase I (Life Technologies) for one hour rotating at 37°C and subsequently passed 
through a 40 µm cell strainer. Erythrocytes were lysed by incubation in 5 ml RBC lysis 
buffer (Table 2-14) for 5 min at room temperature. The lysis was stopped with an equal 
amount of PBS and cells were centrifuged at 300 x g and 22°C for 5 min. Cell pellets were 
resuspended in 1 ml PEB (Table 2-14) and 100 µl were transferred to 5 ml polystyrene 






The left lobe of the perfused lung was harvested into DPBS (Life Technologies). For 
extrapolation to the whole organ the right lobe was harvested into an empty collection 
tube and the weight of both lobes was measured. The left lobe was cut into pieces and 
incubated with 1 mg/ml collagenase IV (C5138, Sigma-Aldrich) and 0.2 mg/ml DNase I 
(Life Technologies) for one hour rotating at 37°C and subsequently passed through a 
40 µm cell strainer. Erythrocytes were lysed by incubation in 5 ml RBC lysis buffer (Table 
2-14) for 5 min at room temperature. The lysis was stopped with an equal amount of PBS 
and cells were centrifuged at 300 x g and 22°C for 5 min. Cell pellets were resuspended in 
1 ml PEB (Table 2-14) and 400 µl were transferred to 5 ml polystyrene tubes or 100 µl to 
wells of a 96-well V-bottom plate for centrifugation and subsequent staining. 
2.1.8.6 Spleen 
The perfused spleen was harvested into PBS and processed through a 40 µm cell strainer. 
Erythrocytes were lysed by incubation in 5 ml RBC lysis buffer (Table 2-14) for 5 min at 
room temperature. The lysis was stopped with an equal amount of PBS and samples were 
centrifuged at 300 x g and 22°C for 5 min. Cell pellets were resuspended in 1 ml PEB 
(Table 2-14) and 100 µl were transferred to 5 ml polystyrene tubes or 100 µl to wells of 
a 96-well V-bottom plate for centrifugation and subsequent staining. 
2.1.8.7 Peyer´s patches 
The small intestine was harvested and flushed with PBS. Peyer´s Patches were carefully 
cut out, processed through a 40 µm cell strainer and centrifuged at 300 x g and 22°C for 
5 min. Cell pellets were resuspended in 1 ml PEB (Table 2-14) and the whole sample was 
transferred to a 5 ml polystyrene tube for centrifugation and subsequent staining.  
 
2.1.9 Adoptive transfer experiments 
Donor cells were isolated from the spleen, several lymph nodes and long bones and 
processed as described in 2.1.8. To investigate trafficking of lymphocytes, cells from 
spleen and pooled lymph nodes were mixed (70:30 ratio). For the investigation of myeloid 
cells, splenic and bone marrow cells (50:50 ratio) were used. Cell counts were obtained 
on a ProCyte Dx® cell counter (IDEXX Laboratories). Donor cells were labeled with 0.1 µM 
CellTracker Deep Red (Thermo Fisher Scientific) or 1.5 µM carboxyfluorescein succimidyl 
ester (CFSE, Thermo Fisher Scientific) in PEB for 20 min at 37°C with subsequent washing 




50:50. One hour after adrenergic stimulation (11 am) about 10 x 106 cells were injected 
intravenously. Subset fractions were obtained by flow cytometric analysis of the donor 
cells. In some experiments, recipient mice were injected intravenously with an antibody 
against the common leukocyte marker CD45, 5 min before harvest at 12 pm, to label cells 
in the circulation. 
 
2.1.10 Flow cytometry 
Single cell suspensions were stained with fluorescence-conjugated antibodies and 
analyzed by flow cytometry using a Gallios Flow Cytometer (Beckman Coulter) or a 
LSRFortessa (BD bioscience) (Table 2-3).  To count the number of cells, 10-15 µl 
CountBrightTM Absolute Counting Beads (Molecular Probes) were added to each sample. 
Data were analyzed with FlowJo software (Tree Star) (Table 2-18). Used staining panels 
and gating strategies are listed below. All used antibodies were specific for mice. 
Table 2-3: Flow cytometer configurations. 
Flow 
Cytometer 
Excitation laser [nm] 
Fluorescence 
channel 






































































































Table 2-4: Staining panel for Blood Leukocyte Subsets (Gallios). 
Laser  
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
405 
Live/Dead DAPI - 1:10 Biolegend London, UK 
CD4 BV570 RM4-5 1:100 Biolegend London, UK 
488 
CD115 PE AFS98 1:100 Biolegend London, UK 
CD3 PE-DZL594 17A2 1:100 Biolegend London, UK 
Gr-1 PerCP/Cy5.5 RB6-8C5 1:100 Biolegend London, UK 





















Figure 2-2: Gating strategy for Blood Leukocyte Subsets (Gallios). 
SS = Side Scatter, FS = Forward Scatter, Neutros = Neutrophils, IM = Inflammatory Monocytes, NIM 










Table 2-5: Staining panel for Blood Leukocyte Subsets (Fortessa). 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
355 Live/Dead DAPI - 1:10 Biolegend London, UK 
405 
CD4 BV605 RM4-5 1:200 Biolegend London, UK 







Gr-1 FITC RB6-8C5 1:200 Biolegend London, UK 
CD8a PerCP/Cy5.5 53-6.7 1:200 Biolegend London, UK 
561 
CD115 PE AFS98 1:100 Biolegend London, UK 
CD3 PE-DZL594/610 17A2 1:200 Biolegend London, UK 
640 















Figure 2-3: Gating strategy for Blood Leukocyte Subsets (Fortessa). 
SS = Side Scatter, FS = Forward Scatter, IM = Inflammatory Monocytes, NIM = Non-Inflammatory 





Table 2-6: Staining panel for Adoptive Transfer with CD45 injection – 
Lymphocytes (Gallios). 
i.v. = intravenous. 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
405 Live/Dead DAPI - 1:10 Biolegend London, UK 
488 
CD3 AlexaFluor488 145-2C11 1:100 Biolegend London, UK 
CD45 PE 30-F11 10 µl i.v. Biolegend London, UK 





CD45 PerCP/Cy5.5 I3/2.3 1:100 Biolegend London, UK 















Figure 2-4: Gating strategy for Adoptive Transfer with CD45 injection – 
Lymphocytes – Donor cells (Gallios). 





Figure 2-5: Gating strategy for Adoptive Transfer with CD45 injection – 
Lymphocytes – Blood (Gallios). 





Figure 2-6: Gating strategy for Adoptive Transfer with CD45 injection – 
Lymphocytes (Gallios).  
The bone marrow was used as example for the gating strategy of recipient organs. The strategy of 




Table 2-7: Staining panel for Adoptive Transfer with CD45 injection – Myeloid cells 
(Gallios). 
i.v. = intravenous. 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
405 Live/Dead DAPI - 1:10 Biolegend London, UK 
488 
Gr-1 FITC RB6-8C5 1:200 Biolegend London, UK 
CD45 PE 30-F11 10 µl i.v. Biolegend London, UK 
CD115 PE-DZL594 AFS98 1:100 Biolegend London, UK 
CD45 PerCP/Cy5.5 I3/2.3 1:100 Biolegend London, UK 


























Figure 2-7: Gating strategy for Adoptive Transfer with CD45 injection – Myeloid 
cells – Donor cells (Gallios). 
SS = Side Scatter, FS = Forward Scatter, IM = Inflammatory Monocytes, NIM = Non-Inflammatory 






Figure 2-8: Gating strategy for Adoptive Transfer with CD45 injection – Myeloid 
cells – Blood (Gallios). 
SS = Side Scatter, FS = Forward Scatter, IM = Inflammatory Monocytes, NIM = Non-Inflammatory 





Figure 2-9: Gating strategy for Adoptive Transfer with CD45 injection – Myeloid 
cells (Gallios).  
The bone marrow was used as example for the gating strategy of recipient organs. The strategy for 
* was applied to all subsets. SS = Side Scatter, FS = Forward Scatter, IM = Inflammatory Monocytes, 




Table 2-8: Staining panel for Adoptive Transfer – Donor Mix (Fortessa). 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
355 Live/Dead DAPI - 1:10 Biolegend London, UK 
405 




















HK1.4 1:400 Biolegend London, UK 

















Figure 2-10: Gating strategy for Adoptive Transfer Donor Mix – Donor cells 
(Fortessa).  





Figure 2-11: Gating strategy for Adoptive Transfer Donor Mix - Blood (Fortessa).  







Figure 2-12: Gating strategy for Adoptive Transfer Donor Mix (Fortessa).  
The bone marrow was used as example for the gating strategy of recipient organs. The strategies 




Table 2-9: Staining panel for Adoptive Transfer - KO recipients (Fortessa). 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
355 Live/Dead DAPI - 1:10 Biolegend London, UK 
405 





CD3 BV711 17A2 1:400 Biolegend London, UK 





HK1.4 1:400 Biolegend London, UK 

















Figure 2-13: Gating strategy for Adoptive Transfer KO recipients – Donor cells 
(Fortessa). 





Figure 2-14: Gating strategy for Adoptive Transfer KO recipients - Blood (Fortessa).  






Figure 2-15: Gating strategy for Adoptive Transfer KO recipients (Fortessa).  
The bone marrow was used as an example for the gating strategy of recipient organs. SS = Side 







Table 2-10: Staining panel for In vitro stimulation of B cells (Fortessa). 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
355 





Live/Dead DAPI - 1:10 Biolegend London, UK 







CD19 FITC 1D3 1:400 Biolegend London, UK 
CD11a PerCP-Cy5.5 M17/4 1:400 Biolegend London, UK 
640 
CXCR4 APC L276F12 1:400 Biolegend London, UK 
CD62L APC-Cy7 MEL-14 1:400 Biolegend London, UK 
 
 
Figure 2-16: Gating strategy for In vitro stimulation of B cells (Fortessa). 









Table 2-11: Staining panel for In vitro stimulation of neutrophils (Fortessa). 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
405 
Ly6C BV421 HK1.4 1:400 Biolegend London, UK 
CD11b BV711 M1/70 1:400 Biolegend London, UK 
Ly6G BV785 1A8 1:400 Biolegend London, UK 
488 
Annexin V FITC - 1:200 Biolegend London, UK 
CXCR4 PerCP/Cy5.5 L276F12 1:400 Biolegend London, UK 
561 





7-AAD PE-Cy5 - 1:200 Biolegend London, UK 






Figure 2-17: Gating strategy for In vitro stimulation of neutrophils (Fortessa). 








Table 2-12: Staining panel for In vivo adhesion molecules (Fortessa). 
Laser 
[nm] 
Antigen Fluorochrome Clone Dilution Company Location 
355 











CD3 BV421 145-2C11 1:200 Biolegend London, UK 





Ly6G BV785 1A8 1:200 Biolegend London, UK 











CXCR4 PE/DZL594 L276F12 1:200 Biolegend London, UK 
CCR7 PE/Cy7 4B12 1:200 Biolegend London, UK 
640 





Ly6C AlexaFluor700 HK1.4 1:200 Biolegend London, UK 






Figure 2-18: Gating strategy for in vivo adhesion molecules (Fortessa). 




2.1.11 Functional blocking experiments 
To block the entry of lymphocytes to LNs, WT mice were injected intraperitoneally with 
neutralizing antibodies against the integrins 4 (CD49d, Table 2-13) and L (CD11a, 
Table 2-13) (von Andrian and Mempel, 2003). To block lymphocyte egress from LNs, the 
S1PR1 blocker FTY720 (Mandala et al., 2002) (Table 2-13) was injected 
intraperitoneally. Directly afterwards, mice were injected intraperitoneally with PBS or 
the specific adrenergic agonists Clenbuterol and BRL37344. Two hours later, at 12 pm, 
blood and LNs were harvested. As control group, untreated or PBS-treated WT mice were 
used. For the block of L-selectin (CD62L) a neutralizing antibody (Table 2-13) or isotype 
control were injected intraperitoneally 24 hours prior to adrenergic stimulation. 
Table 2-13: Blocking antibodies and reagents. 
Antigen/compound Clone Concentration Solution Control Company 
CD11a M17/4 100 µg/mouse PBS - 
Hölzel (Cologne, 
Germany) 
CD49d P/S2 100 µg/mouse PBS - 
Hölzel (Cologne, 
Germany) 
CD62L MEL-14 200 µg/mouse PBS Rat IgG2a 
Hölzel (Cologne, 
Germany) 





2.1.12 In vitro adrenergic stimulation of B cells and neutrophils and investigation 
of adhesion molecule expression 
At 12 pm, spleens from WT mice were harvested and processed through a 40 µm cell 
strainer. After centrifugation at 300 x g and 22°C for 5 min, erythrocytes were lysed by 
incubation in 4 ml RBC lysis buffer (Table 2-14) for 5 min at room temperature. The lysis 
was stopped with an equal amount of PBS and cells were centrifuged at 300 x g and 22°C 
for 5 min. The pellet was resuspended in PBS and 4 x 105 cells were transferred to each 
well of a 96-well V-bottom plate.  Cell counts were obtained from a 1:10 dilution on a 
ProCyte Dx® cell counter (IDEXX Laboratories). 
Bone marrow was obtained at 12 pm from two femora, processed through a 40 µm cell 
strainer and centrifuged at 300 x g and 22°C for 5 min. Erythrocytes were lysed by 
incubation in 4 ml RBC lysis buffer (Table 2-14) for 5 min at room temperature. The lysis 
was stopped with an equal amount of PBS and cells were centrifuged at 300 x g and 22°C 
for 5 min. The pellet was resuspended in PBS and 4 x 105 cells were transferred to each 
well of a 96-well V-bottom plate. Cell counts were obtained from a 1:10 dilution on a 




Cells were incubated with 100 µl PBS or 1 mM of Clenbuterol or BRL37344 for two hours. 
Subsequently, reagents were washed out once with PBS and once with Annexin V Binding 
Buffer (Biolegend) and an antibody mixture for identification of subsets and adhesion 
molecules (Table 2-10 for B cells and Table 2-11 for neutrophils) was added and 
incubated for 30 min at 4°C in darkness. Apoptotic and dead cells were identified using a 
combination of an Annexin V (Biolegend) antibody and 7-AAD (Biolegend). The plate was 
washed once with PBS and cells were resuspended in 190 µl PBS and 10 µl CountBrightTM 
Absolute Counting Beads (Life Technologies).  
 
2.1.13 In vivo imaging of B cells in the popliteal lymph node vasculature 
WT mice were anaesthetized by intraperitoneal injection of ketamine (100 mg/kg, 
Medistar) and xylazine (20 mg/kg, Rompun, Bayer vital GmbH). Hindlegs were shaved 
using a trimmer (Aesculap, GT415, BRAUN) and remaining hair was removed with 
depilation creme (Veet). A catheter consisting of fine tubing filled with isotonic saline and 
attached to the tip of a 30G-needle was inserted into the peritoneum to inject PBS or 
Clenbuterol during imaging. Mice were ventrally secured in an imaging chamber with 
integrated heating pad. After a skin incision above the knee, connective and fat tissue were 
torn to expose the popLN. Using sharp forceps, a small hole was carefully created beneath 
the LN and filled with PBS-soaked tissue pieces to lift the LN slightly out of the tissue. The 
tissue was kept moist by draping wet tissue paper around the skin incision. A cover glass 
(35 mm) was placed on top of the exposed LN and fixed in the imaging stage. Blood vessels 
were visualized by intravenous injection of FITC-Dextran (20 µl, average molecular 
weight 150,000; Sigma-Aldrich) and B cells were visualized by intravenous injection of a 
fluorescence-labeled antibody (B220-PE, 5 µl, clone RA3-6B2, Biolegend) 5 min prior to 
imaging with a Zeiss Axio Examiner.Z1 confocal spinning disk microscope (Table 2-19) 
equipped with 405, 488, 561, and 640 nm laser sources. After a control video of about 
15 min, 100 µl of either PBS or Clenbuterol (2 mg/kg) were administered through the 
peritoneal catheter and B cells in the superficial vasculature were imaged for about one 
hour until 12 pm. Analysis of the 4D intravital imaging was performed using ImageJ 
(version 1.51n) and Slidebook (version 6, Intelligent Imaging Innovations, 3i) (Table 
2-18). To measure the time-dependent change in adhesion, videos were sum projected 
and subsequently the mean fluorescence intensity (MFI) of adherent cells within 
individual vessels was measured. Relative adhesion was calculated as percent increase 




and the MFIs of individual time points upon treatment (n(mice) = 2 (PBS/Clenbuterol); 
n(vessels) = 3-5). 
 
2.1.14 Statistical analysis 
Collective data sets were obtained by pooling data from the same experimental setups. 
Statistical analyses were performed using GraphPad Prism 6 or 8 software (Table 2-18). 
All data are represented as mean ± SEM. An unpaired student‘s t-test was used for 
comparison between two groups. For comparison of three or more groups with one 
variable, one-way ANOVAs followed by Tukey‘s, Dunnett‘s or Mann-Whitney‘s post hoc 
test were performed. For comparison of three or more groups with two variables, two-
way ANOVAs with Dunnett‘s or Sidak‘s post hoc test were used. Statistical significance was 







Table 2-14: Buffer ingredients. 
Buffer Supplements 
Genotyping digestion buffer 0.5 mM EDTA, 0.1 M Tris, 0.2% SDS, 0.2 M NaCl (pH 8.5) 
PEB PBS, 2 mM EDTA, 20% FCS 
RBC lysis buffer 0.154 mM NH4Cl, 0.05 mM EDTA, 10 mM KHCO3 (pH 7.25) 
Tris-Acetate-EDTA (TAE) 
buffer 
2 M Tris, 50 mM EDTA, 1 M acetic acid 
Tris-EDTA (TE) buffer 2 M Tris, 50 mM EDTA 
 
2.2.2 Reagents 
Table 2-15: List of used reagents with respective suppliers. 
Reagent Company Location 
Agarose Biozym Scientific Oldendorf, Germany 
Ammonium chloride (NH4Cl) Merck Darmstadt, Germany 
Annexin V Binding Buffer Biolegend London, UK 
BRL37344 Sigma-Aldrich Munich, Germany 
CellTraceTM CFSE Thermo Fisher Scientific Munich, Germany 
CellTrackerTM Deep Red Thermo Fisher Scientific Munich, Germany 
Clenbuterol Sigma-Aldrich Munich, Germany 
Collagenase IV Sigma-Aldrich 
Taufkirchen, 
Germany 
CountBrightTM Absolute Counting 
Beads 
Life Technologies Darmstadt, Germany 
4‘,6-diamidino-2-phenylindole 
(DAPI) 
Biolegend London, UK 
Denopamine Sigma-Aldrich Munich, Germany 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich Munich, Germany 
DNAse I AmbionTM Life Technologies Darmstadt, Germany 
DPBS Life Technologies Darmstadt, Germany 
Ethylenediaminetetraacetic acid 
(EDTA) 
Life Technologies Darmstadt, Germany 
FastGene 100 bp DNA Marker Nippon Genetics Düren, Germany 
FastGene Optima PCR HotStart Nippon Genetics Düren, Germany 
Fetal Calf Serum (FCS) Life Technologies Darmstadt, Germany 
Fluorescein isothiocyanate (FITC)-
Dextran (150,000) 
Sigma-Aldrich Munich, Germany 
FTY720 (Fingolimod) Sigma-Aldrich Darmstadt, Germany 
Histoacryl glue B. Braun AG Puchheim, Germany 
HyPureTM Molecular Biology Grad 
Water (nuclease-free) 
GE Healthcare LifeSciences 
South Logan, Utah, 
USA 
Isoflurane CP-Pharma Burgdorf, Germany 
Isopropanol (Propan-2-ol) AppliChem Darmstadt, Germany 
Isoproterenol Sigma-Aldrich Munich, Germany 
Ketamine Medistar Munich, Germany 
Midori Green Advance Nippon Genetics Düren, Germany 
Phosphate-buffered saline (PBS) Apotheke Klinikum München Munich, Germany 
Potassium hydrogen carbonate 
(KHCO3) 
Merck Darmstadt, Germany 
Propranolol Sigma-Aldrich Munich, Germany 




Reagent Company Location 
Sodium chloride (NaCl) Sigma-Aldrich 
Taufkirchen, 
Germany 
Sodium dodecyl sulfate (SDS) 10% Sigma-Aldrich 
Taufkirchen, 
Germany 
Tris AppliChem Darmstadt, Germany 
UltraComp eBeadsTM 
Compensation Beads 
Thermo Fisher Scientific Munich, Germany 
Veet Depilation Creme 
Reckitt Benckiser Deutschland 
GmbH 
Heidelberg, Germany 
Xylazine (RompunTM) Bayer vital GmbH Leverkusen, Germany 
 
2.2.3 Materials 
Table 2-16: List of used materials with respective suppliers. 
Material Company Location 
Cell strainer (40 µm) Thermo Fisher Scientific Darmstadt, Germany 
Cover glass (35 mm) Thermo Fisher Scientific Darmstadt, Germany 
Microhematocrit tubes VWR Darmstadt, Germany 
Polyethylene tubing Smiths Medical Deutschland GmbH Grasbrunn, Germany 
PopLN imaging stage Built in-house Munich, Germany 
 
2.2.4 Devices 
Table 2-17: List of used devices and respective suppliers. 
Device Company Location 
Aesculap Exacta Cordless Dog 
Grooming Trimmer 
Aesculap AG, BRAUN Tuttlingen, Germany 
Electrophoresis Chamber BioRad Munich, Germany 
Gallios Flow Cytometer Beckman Coulter Krefeld, Germany 
Heraeus Multifuge X3R Thermo Fisher Scientific Munich, Germany 
Isoflurane Chamber Groppler Medizintechnik Deggendorf, Germany 
LSRFortessa Flow Cytometer 
(Munich) 
BD bioscience Heidelberg, Germany 
Mastercycler Epgradient S Eppendorf Munich, Germany 
Mastercycler Nexus Eppendorf Munich, Germany 
Minicentrifuge Eppendorf Munich, Germany 
PowerPac Basic BioRad Munich, Germany 
ProCyte Dx® IDEXX Laboratories Hoofddorp, Netherlands 
Spinning Disk Microscope Zeiss Jena, Germany 
ThermoMixer F1.5 Eppendorf Munich, Germany 
UV Transilluminator Gel 
Imaging Chamber 
INTAS Science Imaging Göttingen, Germany 
UVP Minidizer Oven Analytik Jena Jena, Germany 







Table 2-18: List of used software with respective suppliers. 
Software Company Location 
Excel Microsoft USA 
GraphPad Prism 6&8 GraphPad Software La Jolla, CA, USA 
FlowJoTM V10.6.2 Becton Dickinson GmbH Heidelberg, Germany 
Fiji Version 1.51n Open-Source USA 
SlideBook Version 6 Intelligent Imaging Innovations, 3i Göttingen, Germany 
 
2.2.6 Microscope configuration 
























405 387/11 382-391 
488 485/20 475-495 
561 560/25 552-572 
640 650/13 644-656 







3.1 Overview of the experimental design 
 
As an overview, the scientific questions and respective experiments are summarized in 
Figure 3-1. 
 
Figure 3-1: Overview of the scientific questions and the experimental design. 
Scientific questions in gray boxes were approached with respective experiments in yellow boxes. 
Figure numbers showing respective data are indicated in blue circles. AR = adrenoceptor, Adrb2/3 




3.2 Stimulation of -ARs affects leukocyte numbers in blood 
 
In a first experiment, WT mice were intraperitoneally injected with PBS, the pan--AR 
agonist Isoproterenol (Iso) or the pan--AR antagonist Propranolol (Prop) two hours 
prior to blood harvest (see 2.1.5). Total leukocyte as well as subset counts were obtained 
using flow cytometry. As numbers of leukocytes in blood oscillate throughout the day, 
peaking at 12 pm and troughing at 8 pm in mice (Druzd et al., 2017; He et al., 2018; 
Scheiermann et al., 2012), samples were harvested at these two time points. Time-of-day 
differences were verified for white blood cell (WBC), B cell, CD8+ T cell, inflammatory 
monocyte (Infl. Monos) and eosinophil counts in the PBS control, whereas differences in 
other subset counts were not significant, but exhibited a trend to decreased circulating 
numbers at night. At 12 pm, no differences were detectable in WBC counts between the 
treatments, whereas at 8 pm, leukocyte numbers were increased after injection of the pan-
-AR agonist Iso. The pan--AR antagonist Prop showed a small effect in the evening 
compared to the control (Figure 3-2A). Neutrophil numbers showed similar results 
during day and night, with significantly elevated numbers in blood upon pharmacological 
stimulation of -ARs. Prop injection had a small, but not significant effect at both time 
points, in that neutrophil numbers were slightly reduced compared to the PBS control. B 
cell numbers, on the other hand, showed inversed effects. Circulating numbers were 
drastically reduced upon activation of -ARs. However, effects were only visible during 
the day, as numbers in blood were low at night already. Injection of the antagonist Prop 
led to slightly increased, but again not significantly changed numbers of B cells at both 
time points (Figure 3-2A). Other lymphocyte subsets (CD4+ and CD8+ T cells) were not 
significantly affected by Iso and Prop administration, although Prop slightly increased 
numbers during both time points. Additionally, CD8+ T cell numbers were marginally 
higher upon agonism at night (Figure 3-2A). Monocytes and NK cells were not affected by 
either pharmacological agent. Eosinophil numbers were reduced during the day upon -
AR stimulation, while circulating numbers at night were already low (Figure 3-2A). Due 
to the fact that neutrophils and B cells exhibited the most distinctive – and opposite – 
results, in the following only these two subsets will be highlighted.  
 
Since antagonism of -AR signaling by Prop injection did not strongly influence circulating 
leukocyte numbers, the impact of a chemical sympathectomy was tested. Therefore, mice 
received the neurotoxin 6-hydroxydopamine (6-OHDA) intraperitoneally over two 




On day five of the experiment, blood was harvested at 12 pm and leukocyte counts were 
obtained using flow cytometry (see 2.1.6). Neither for total leukocyte counts, nor for 
neutrophils and B cells was a difference detected between control and sympathectomized 
mice (Figure 3-2B, for other subsets see Figure 6-1). Taken together, these data suggest a 
role for -AR signaling in the regulation of circulating leukocyte numbers, whereas 
blocking showed minor effects and absence of the sympathetic tone affected their 







Figure 3-2: Effects of agonism or antagonism/absence of sympathetic signaling on 
circulating leukocyte numbers. 
(A) Leukocyte numbers in blood after agonism or antagonism of -ARs during day and night. WT 
mice were injected with PBS, the pan--AR agonist Isoproterenol (Iso) or the pan--AR antagonist 
Propranolol (Prop) 2hrs prior to blood harvest at 12 pm (yellow) or 8 pm (gray). Cell counts were 
obtained using flow cytometry.  n = 6-10, two-way ANOVA, Tukey‘s test. (B) WBC, neutrophil and 
B cell numbers in blood after ablation of the sympathetic tone during the day. WT mice were 
injected with PBS (gray) or 6-hydroxydopamine (6-OHDA, blue) on day zero and day two, blood 
was harvested at 12 pm on day five of the treatment.  n = 5, student‘s t-test. WBC = White blood 





3.3 Blood leukocyte numbers are controlled by 2- and 3-ARs 
 
To investigate which of the three family members of -ARs were involved in the regulation 
of blood leukocyte numbers, specific pharmacological agonists were used. 1-ARs were 
stimulated by injection of Denopamine (Den), 2-ARs by Clenbuterol (Clen) and 3-ARs by 
BRL37344 (BRL) two hours prior to blood harvest at 12 pm or 8 pm (see 2.1.5).  
Cell counts in DMSO and Den-treated mice did not differ from each other, neither at 12 pm 
nor at 8 pm (Figure 3-3A). Thus, 1-ARs were not involved in the observed phenotypes in 
Figure 3-2A.  
Upon injection of Clen and BRL, similar results to stimulation with Iso (Figure 3-2A) were 
observed. WBC counts between treatments were not altered at 12 pm, due to increased 
neutrophil and decreased B cell numbers at this time point, which might cancel each other 
out (Figure 3-3B). Effects were even more dramatic for neutrophils at night, since murine 
blood already contains fewer cells at this time of day. Because of the same reason, 
circulating B cell numbers did not change at 8 pm. As differences in numbers of both 
leukocyte subsets were observed during the day time point, experiments in the following 
sections were only performed at 12 pm. Results for other circulating leukocyte subsets 
can be found in Figure 6-2. 
To investigate the influence of adrenergic stimulation under inflammatory conditions, WT 
mice received TNF one hour before they were injected with PBS or the specific agonists 
(see 2.1.7). Under inflammatory conditions, the time-of-day difference in PBS-treated 
mice was gone (except for B cells) and WBC counts were slightly reduced (Figure 3-3C) in 
comparison to steady state (Figure 3-3B). Neutrophil counts were not significantly 
altered upon adrenergic stimulation after TNF administration, but showed a similar 
trend as under steady state, in that numbers increased upon Clen injection. The dramatic 
differences in B cell numbers were annihilated, predominantly due to lower numbers after 
TNF administration (0.5x106 cells/ml vs. 1.5x106 cells/ml under steady state), 
suggesting that in an inflammatory scenario, adrenergic stimulation does not affect 
circulating leukocyte numbers to the same extent as under homeostasis.  
Since B cell numbers in blood decreased upon adrenergic stimulation, it was tested 
whether administration of the agonists leads to augmented cell death. Using flow 
cytometry, B cells positive for the live/dead staining DAPI were identified (Figure 3-3D). 
Depicted as percentage of total B cells, it was demonstrated that administration of Clen 
and BRL did not increase numbers of dead cells, indicating that B cells were redistributed 




direct contact between cells and agonists causes cell death. For this, B cells isolated from 
the spleen were incubated with the agonists for two hours. As shown in  Figure 3-3E, the 
ratio of dead B cells was not higher in treated samples. Taken together, these data 
demonstrate that treatment with Clen and BRL increased circulating neutrophil numbers 
while decreasing circulating B cell numbers by redistribution of these leukocyte subsets. 
So far, blood was harvested two hours after intraperitoneal administration of the 
pharmacological agonists. To evaluate the temporal profile of the effects on leukocyte 
numbers in blood, an experimental time course was performed, where blood was 
harvested 10 min, 60 min, 120 min and 360 min after injection. As shown in Figure 3-3F, 
two hours between treatment and harvest were effectual to alter circulating leukocyte 







Figure 3-3: Changes in blood leukocyte numbers are mediated by 2- and 3-ARs. 
(A) Cell counts in blood upon stimulation of 1-ARs. WT mice were injected with DMSO or 
Denopamine (Den) 2hrs prior to harvest at 12 pm (yellow) or 8 pm (gray). n = 6, two-way ANOVA, 
Tukey‘s test. (B) Cell counts in blood upon stimulation of 2- and 3-ARs. WT mice were injected 
with PBS, Clenbuterol (Clen) or BRL37344 (BRL) 2hrs prior to harvest at 12 pm (yellow) or 8 pm 
(gray). n = 5-6, two-way ANOVA, Tukey‘s test. (C) Cell counts in blood upon stimulation of 2- and 
3-ARs under inflammation. WT mice received TNF and PBS or the adrenergic agonists. Blood was 
harvested at 12 pm (yellow) or 8 pm (gray). n = 5-6, two-way ANOVA, Tukey‘s test. (D) Fractions 
of dead B cells after in vivo stimulation for 2hrs. n = 3, one-way ANOVA, Dunnett‘s test. (E) Fraction 
of dead B cells after in vitro stimulation for 2hrs. n = 6, one-way ANOVA, Dunnett‘s test. (F) Time 
course of harvest time. Cell counts in blood after different times between injection and harvest. 




3.4 Neutrophils are redistributed upon adrenergic stimulation 
 
3.4.1 2-ARs influence recruitment, 3-ARs influence mobilization of neutrophils 
To investigate whether increased circulating neutrophil numbers were attributed to 
enhanced mobilization into blood and/or impaired recruitment from blood, an adoptive 
transfer of donor cells into stimulated recipients was performed (see 2.1.9) with 
subsequent analysis of donor and endogenous cells in various organs. Cells extracted from 
spleen and BM were mixed and stained to allow tracing after injection. Recipients were 
intraperitoneally injected with PBS or the adrenergic agonists Clen (2-AR) or BRL (3-
AR) and one hour later received the donor cells intravenously. After another hour, in 
which donor cells circulated through the system, mice were intravenously injected with a 
fluorescently labeled antibody against the common leukocyte marker CD45. Five minutes 
later, at 12 pm, blood was harvested and mice were perfused to remove non-adherent 
cells from the circulation. Subsequently, the femur, spleen, liver, and lung were harvested 
(Figure 3-4A). Together with blood, organs were processed for flow cytometry and 
stained for leukocyte subsets. Using another clone and fluorescent label of a CD45 
targeting antibody during processing, leukocytes within the circulation (double positive) 
could be distinguished from extravascular cells that immigrated into the tissue (single 
positive). Where sampling of the whole organ was not practical (as for the liver and lung), 
leukocyte numbers were extrapolated for the whole organ. The same applied for the 
blood, which was estimated to be 2 ml per mouse.  
Endogenous neutrophil numbers in blood were elevated upon injection of either -AR 
agonist (Figure 3-4B), confirming the results in Figure 3-3B. Interestingly, in the BM 
(represented by two femora), administration of BRL led to a reduction of neutrophil 
numbers by about five million cells, suggesting that these cells could be mobilized from 
the BM (Figure 3-4B). Numbers were increased in the liver, in which the 3-AR agonist 
showed a more dramatic effect (six-fold). In the lung, both agonists increased neutrophil 
numbers to the same extent. The spleen exhibited more endogenous neutrophils upon 
treatment with BRL. The distribution of other endogenous myeloid subsets is displayed 
in Figure 6-5. 
Detected endogenous neutrophils in each organ were then subdivided into CD45-single 
positive extravascular cells and CD45-double positive intravascular cells, shown as 
percentage of the overall detected cells (Figure 3-4C). Supporting the suggestion that 
neutrophils might be mobilized from the BM upon stimulation of 3-ARs, injection of BRL 




cells in this tissue. The opposite was the case in the liver, where more extravascular 
neutrophils could be detected upon BRL injection. In the lung and spleen, adrenergic 
stimulation did not change the localization of neutrophils. Localization data obtained for 
other endogenous myeloid subsets can be found in Figure 6-6. 
To examine whether neutrophil homing was impaired by adrenergic stimulation, the 
percentage of injected donor neutrophils in blood and each organ was calculated (Figure 
3-4D). Upon injection of the 2-AR agonist Clen, the percentage of donor neutrophils in 
blood was significantly increased, suggesting a reduced recruitment to tissues. 
Stimulation of 3-ARs did not show an effect, supporting the hypothesis of higher blood 
counts due to enhanced mobilization from the BM. Additionally, in BM no effect in 
neutrophil homing could be observed. Taken together, these data suggest that 3-ARs 
might be involved in mobilization rather than homing of neutrophils, whereas for 2-ARs 
the opposite could be the case. Similar to endogenous neutrophils, pharmacological 
stimulation of 3-ARs also increased the percentage of donor neutrophils in the liver, 
whereas in the lung, 2-ARs could be involved in neutrophil homing, as the percentage of 
detected neutrophils showed almost a two-fold increase upon injection of Clen. 
Neutrophil homing to the spleen was not affected by any of the agonists. The distribution 
of other adoptively transferred myeloid cells is illustrated in Figure 6-7. 
Although adrenergic stimulation of the recipients did not have an impact on donor 
neutrophil numbers in the BM, their localization within the organ was altered, in that 
slightly more (4%) intravascular cells were detected upon 2-AR stimulation by Clen 
(Figure 3-4E), indicating that adoptively transferred neutrophils adhered to the 
vasculature as a first step of homing to the BM. In the liver, very similar results were 
obtained for donor neutrophils as for endogenous cells, manifesting a 25% higher 
extravascular fraction upon BRL injection. The localization of injected neutrophils in the 
lung and spleen was not affected. In general, a relatively high percentage of injected 
neutrophils could be detected in the tested organs (Table 3-1), predominantly due to 
retention of the majority of cells in the blood. Taken together, presented data suggest a 
dual role of adrenergic signaling in the redistribution of neutrophils, as 2-ARs influenced 
homing and 3-ARs impacted mobilization of this leukocyte subset. The intra- and 






Figure 3-4: Neutrophils are redistributed by adrenergic stimulation.  
(A) Illustration of the experimental design. Recipient mice were intraperitoneally injected with 
PBS, Clenbuterol (Clen) or BRL37344 (BRL) and received 1hr later the stained donor cells. At 
12 pm, a CD45 labeling antibody was injected and blood was harvested 5 min later. Mice were 
perfused and organs were harvested and processed for flow cytometry. (B) Endogenous neutrophil 
numbers in blood and organs after injection of PBS or the specific agonists, extrapolated to 2 ml of 
blood or the whole organ, respectively. n = 5-39, one-way ANOVA, Dunnett‘s test. (C) Intravascular 
(red) and extravascular (blue) endogenous neutrophils as percentage of the detected cells in the 
respective organs. n = 5-6, two-way ANOVA, Dunnett‘s test. (D) Detected donor neutrophils in 
blood and organs as percentage of the injected cells. n = 5-6, one-way ANOVA, Dunnett‘s test. (E) 
Intravascular (red) and extravascular (blue) donor neutrophils as percentage of the detected cells 







Table 3-1: Donor neutrophils as percentage of injected neutrophils in blood and 
organs.  
Data are presented as mean ± SEM. BM = bone marrow. 
 Blood BM Spleen Liver Lung Total 
PBS 6.33 ± 2.00 3.20 ± 0.30 2.11 ± 0.97 1.67 ± 0.45 2.88 ± 0.54 16.19 ± 4.26 
Clen 44.92 ± 10.91 3.18 ± 0.57 2.09 ± 1.52 2.12 ± 0.51 5.32 ± 0.58 57.63 ± 14.09 
BRL 16.51 ± 2.50 2.86 ± 0.33 2.13 ± 0.97 3.77 ± 0.46 4.06 ± 0.69 29.33 ± 4.95 
 
 
3.4.2 Neutrophil adhesion molecule levels change upon adrenergic stimulation 
To shuttle between blood and tissues, leukocytes utilize specific sets of adhesion 
molecules and chemokine receptors that interact with their binding partners on 
endothelial cells of the respective vascular beds. After observing a redistribution of 
neutrophils between blood and organs, a putative effect of adrenergic stimulation on 
adhesion molecule and chemokine receptor levels on the surface of this leukocyte subset 
was investigated. In an in vivo approach (performed by Chen Wang), mice were injected 
intraperitoneally with PBS, Clen or BRL. Two hours later, at 12 pm, blood was harvested 
and processed for flow cytometry, where mean fluorescence intensities (MFIs) of CD11b 
(part of Mac-1), CXCR4, CD162 (PSGL-1), CD62L (L-selectin) and CD49d (part of VLA-4) 
were recorded (Table 2-12).  
On circulating neutrophils, which accumulated in blood upon adrenergic stimulation 
(Figure 3-4B), injection of Clen led to decreased surface levels of the adhesion molecule 
CD11b, which is part of the Mac-1 integrin complex. In contrast, levels of CXCR4 were 
increased upon administration of both, Clen and BRL. Levels of CD162 were not altered. 
Although not significantly, CD62L levels were increased when mice were injected with 
Clen. CD49d levels were downregulated upon Clen-injection (Figure 3-5A). As CD62L is 
shed upon activation, its upregulation upon stimulation of 2-ARs confirmed the 
assumption from adoptive transfer experiments (Figure 3-4D) in that cells could be 
hindered to leave the blood due to impaired recruitment. Downregulation of the integrin 
CD11b supported this hypothesis whereas upregulation of CXCR4 indicated that 
neutrophils might home back to the BM, for which this chemokine receptor is crucial. 
However, expression levels of CXCR4 and CD49d were generally low. 
To ascertain direct effects of the adrenergic agonists on adhesion molecule levels of 
neutrophils, cells obtained from BM were seeded in a 96-well plate and incubated in vitro 
with Clen or BRL for two hours. Using flow cytometry, MFIs of CD11b, CXCR4, CD162 and 
CD62L were measured and are shown in Figure 3-5B. Although CXCR4 levels exhibit the 




same applied for the other tested adhesion molecules and chemokine receptors. Taken 
together, these data present evidence that adhesion molecule levels on neutrophils are 
altered, leading to a less activated state of the cells, which could explain why neutrophil 
numbers in blood were increased, as cells could not leave the circulation. Furthermore, 
direct stimulation of neutrophils did not show effects on molecule levels, hinting to an 




Figure 3-5: Adhesion molecule levels on neutrophils are altered upon adrenergic 
stimulation. 
(A) MFI of several molecules on circulating neutrophils after in vivo adrenergic stimulation. WT 
mice were intraperitoneally injected with PBS (gray), Clenbuterol (Clen, orange) or BRL37344 
(BRL, yellow) 2hrs prior to blood harvest at 12 pm. n = 6, one-way ANOVA, Dunnett‘s test. 
Experiment was performed by Chen Wang. (B) MFI of several molecules on neutrophils after in 
vitro adrenergic stimulation. BM from WT mice was harvested and processed. Cells were seeded 
into 96-well plates and stimulated in vitro with PBS, Clen or BRL for 2hrs. n = 3, one-way ANOVA, 





3.4.3 2-ARs of neutrophils and their environment are targeted 
Since in vivo stimulation with adrenergic agonists affected adhesion molecule levels on 
neutrophils differently than stimulation in vitro (Figure 3-5), it was further investigated 
whether this leukocyte subset was directly targeted or whether cells in the 
microenvironment were responsible for their redistribution. Therefore, reciprocal 
adoptive transfers between WT mice and mice lacking 2-ARs (Adrb2 KO) were 
performed (see 2.1.9). WT or KO cells were intravenously injected into stimulated WT 
recipients, or WT donor cells were injected into stimulated WT or KO recipients. After one 
hour of circulation, blood from recipients was harvested at 12 pm, mice were perfused 
and the femur, spleen, liver, and lung were harvested and together with blood processed 
for flow cytometry (Figure 3-6A).  
First, endogenous neutrophil numbers in WT and Adrb2 KO mice were screened after 
PBS- or Clen-injection (Figure 3-6B). Although not significant, WT recipients possessed 
more endogenous neutrophils in their blood after Clen injection, reproducing previous 
experiments (Figure 3-4B). This effect was not observable in blood of mice lacking 2-ARs, 
confirming that Clen-induced augmentation of circulating neutrophils was mediated by 
2-ARs. As expected, no effect of 2-AR stimulation in the BM was observed. No significant 
changes were detectable in the spleen either, especially due to the high deviation in Clen-
stimulated WT mice. In the liver and lung, neutrophil numbers in Clen-stimulated WT 
mice should have been increased, which was slightly the case in the liver, but not in the 
lung. This shows that neutrophil homing to these organs under adrenergic stimulation is 
not robust and could be therefore unspecific. Taken together, no effects of Clen-treatment 
on neutrophil numbers in organs of Adrb2 KO mice were observed, confirming that 
neutrophil redistribution was 2-AR specific. Interestingly however, the lung of Adrb2 KO 
mice harbored more than three times as much endogenous neutrophils than WT mice, 
indicating that the pulmonary marginated pool might require the presence of 2-ARs 
(Figure 3-6B). 
In a next step, it was examined whether cell-intrinsic 2-ARs were involved in the 
observed phenotype of neutrophil redistribution. For this, WT or Adrb2 KO donor cells 
were injected into PBS- or Clen-treated WT recipients (Figure 3-6C). Data are presented 
as fraction normalized to WT donor cells in the PBS-treated control group. In blood, WT 
donor neutrophils were accumulated, reproducing the results shown in Figure 3-4D. This 
change was observed to a lesser extent when Adrb2 KO donor neutrophils were injected 
into pharmacologically stimulated WT mice, indicating that 2-ARs on neutrophils were 




changes were expected and assessed in the BM, spleen and liver, although the latter 
exhibited elevated WT donor neutrophils upon Clen injection. Increased homing of WT 
donor neutrophils to the lung was anticipated, but not detected, supporting the 
assumption that homing to this tissue might have been unspecific.  
Adrenoceptors are not only expressed by leukocytes, but also by a wide variety of stromal 
cells. Thus, it was investigated whether 2-ARs on these microenvironmental cells play a 
role in the adrenergic redistribution of neutrophils. Figure 3-6D depicts the fraction of 
WT donor neutrophils in PBS- or Clen-treated WT or Adrb2 KO recipients, normalized to 
donor cells in the PBS-treated control. In blood of WT recipients treated with Clen, WT 
donor neutrophils exhibited the expected significant increase in cell numbers, which did 
not hold true for WT neutrophils in mice lacking 2-ARs (Figure 3-6D). Due to lower 
differences in a KO environment compared to differences in numbers of KO donor 
neutrophils in a WT environment (Figure 3-6C), it can be assumed that the involvement 
of 2-ARs on stromal cells is greater than that of receptors on neutrophils. In BM, no 
changes of WT donor cell homing to Clen-stimulated WT mice were registered in previous 
experiments (Figure 3-4C), but in this experimental setting less WT donor neutrophils 
homed to the BM, which was not the case for cells lacking 2-ARs (Figure 3-6D). No 
significant changes were detectable in the other tested organs. Summed up, reciprocal 
adoptive transfers between WT and Adrb2 KO mice revealed that 2-ARs primarily on 
stromal cells, but also on neutrophils influenced the distribution of neutrophils between 






Figure 3-6: 2-ARs of neutrophils and their environment are targeted.  
(A) Illustration of the experimental design. WT or Adrb2 KO mice were injected with PBS (gray) or 
Clenbuterol (Clen, orange) and received 1hr later mixed WT and Adrb2KO donor cells. Another 
hour later, at 12 pm, blood was harvested, mice were perfused and organs were harvested for flow 
cytometry. (B) Endogenous neutrophil numbers in blood and organs of PBS- or Clen-injected 
recipients. Cell counts were extrapolated to 2 ml of blood or the whole organ. n = 6, two-way 
ANOVA, Sidak‘s test. (C) Fraction of WT or Adrb2KO donor neutrophils in blood and organs of WT 
recipients, normalized to WT donor cells in the PBS-injected control. n = 6, two-way ANOVA, Sidak‘s 
test. (D) Fraction of WT donor neutrophils in PBS- or Clen-treated WT or Adrb2KO recipients. n = 6, 
two-way ANOVA, Sidak‘s test. WT = Wild type, Adrb2KO = 2-adrenoceptor knockout, D = Donor, 
R = Recipient. 
 
 
To ascertain the contribution of cell-intrinsic and microenvironmental 3-ARs in the 
observed effects, the same approach was performed with mice systemically lacking 3-
ARs (Adrb3 KO). WT or Adrb3 KO cells were injected into PBS- or BRL-treated WT 
recipients and WT donor cells were injected into stimulated WT or Adrb3 KO recipients. 
At 12 pm, blood was harvested and mice were perfused. A femur, the spleen as well as the 




To test whether effects observed by BRL injection were intrinsically mediated by 3-ARs, 
endogenous neutrophil numbers in blood and organs of stimulated WT and Adrb3 KO 
mice were investigated (Figure 3-7B). In blood of WT mice, injection of BRL was expected 
to raise endogenous neutrophil numbers, as shown in Figure 3-4B. However, this was not 
the case here, making an interpretation more difficult. In previous experiments, 
endogenous neutrophils left the BM upon 3-AR stimulation (Figure 3-4B), of which a 
tendency was detected in this experiment as well. Interestingly, endogenous neutrophil 
numbers were generally higher in Adrb3 KO mice, again pointing to a role of 3-ARs in the 
mobilization of these cells from the BM. No significant changes were observed in 
endogenous cell numbers in the other tested organs, although increased endogenous 
neutrophil numbers in liver and lung of BRL-stimulated WT mice were expected.  
Next, the involvement of neutrophil-intrinsic 3-ARs was investigated. Therefore, WT or 
Adrb3 KO donor cells were injected into PBS- or BRL-treated WT recipients (Figure 3-7C). 
In agreement with the outcome in Figure 3-4D, no changes of WT donor neutrophil 
numbers in blood of PBS- or BRL-treated WT mice were assessed. Interestingly, more 
donor neutrophils lacking 3-ARs remained in the circulation, but as mentioned for 
endogenous numbers in blood it is difficult to interpret the data. Donor cells of both 
genotypes exhibited the same phenotype in BM, namely reduced homing to the tissue 
upon treatment with BRL. This suggests that 3-ARs on neutrophils do not play a role in 
enhanced mobilization from the BM. In general, no significant differences were found 
between WT and Adrb3 KO donor cells in the spleen, liver and lung, indicating that 3-ARs 
on neutrophils were not involved in the observed redistribution to these organs.   
Hence, it was assumed that receptors on cells of the neutrophil environment played a 
major role in the observed phenomena. To investigate this, WT donor cells were injected 
into PBS- or BRL-treated WT or Adrb3 KO recipients (Figure 3-7D). Whereas no effects 
were observed in the blood, spleen, liver and lung, fractions of donor cells significantly 
differed between BM samples from PBS-treated and BRL-treated WT recipients. Since the 
effect in BRL-stimulated WT mice was not observed in BRL-stimulated Adrb3 KO mice, it 
can be assumed that in the BM, BRL specifically targeted 3-ARs. Thus, data collected in 
the reciprocal adoptive transfer with Adrb3 KO mice are difficult to interpret, but in BM 






Figure 3-7: Stimulation of 3-ARs could affect neutrophil distributions. 
(A) Illustration of the experimental design. WT or Adrb3KO mice were injected with PBS (gray) or 
BRL37344 (BRL, yellow) and received 1hr later mixed WT and Adrb3KO donor cells. Another hour 
later, at 12 pm, blood was harvested, mice were perfused and organs were harvested for flow 
cytometry. (B) Endogenous neutrophil numbers in blood and organs of PBS- or BRL-injected 
recipients. Cell counts were extrapolated to 2 ml of blood or the whole organ. n = 6, two-way 
ANOVA, Sidak‘s test. (C) Fraction of WT or Adrb3KO donor neutrophils in blood and organs of WT 
recipients, normalized to WT donor cells in the PBS-injected control. n = 6, two-way ANOVA, Sidak‘s 
test. (D) Fraction of WT donor neutrophils in PBS- or BRL-treated WT or Adrb3KO recipients. n = 6, 
two-way ANOVA, Sidak‘s test. WT = Wild type, Adrb3KO = 3-adrenoceptor knockout, D = Donor, 





3.5 B cells are redistributed upon adrenergic stimulation 
 
3.5.1 Clenbuterol administration might promote B cell homing to LNs 
As shown in Figure 3-3B, endogenous B cells left the blood stream after injection of the 
adrenergic agonists Clen (2-AR) and BRL (3-AR). To investigate their destination, 
multiple organs were examined. PBS or the adrenergic agonists were administered two 
hours prior to the injection of a CD45 labeling antibody and blood harvest at 12 pm. After 
perfusion, the femur, liver, lung and spleen were harvested. Since B cells mainly circulate 
through lymphoid organs, LNs draining different areas were included in the analysis 
(Figure 3-8A).  
Reduced endogenous B cell numbers in blood from previous experiments (Figure 3-3B) 
were confirmed, as injection of both agonists mitigated circulating B cell numbers by 
three-fold (Figure 3-8B). Administration of BRL led to decreased B cell numbers in the 
BM, which – similar to neutrophils – indicates a role of 3-ARs in the mobilization of B 
cells. In the liver and lung, -AR stimulation reduced endogenous numbers as well. Thus, 
the investigated organs were not target of B cells leaving the circulation due to treatment 
with the adrenergic agonists. Since B cells mainly circulate through the spleen and LNs it 
was expected that cells might migrate to these secondary lymphoid organs. To explore 
this, two head/ear/neck-draining superficial parotid LNs (spLNs), an abdomen-draining 
mesenteric LN (mLN) and both skin-draining inguinal LNs (iLNs) were harvested to allow 
the examination of different body compartments. However, endogenous B cell numbers 
in these tissues were not significantly raised by Clen and BRL administration (Figure 
3-8B), probably due to already high amounts of B cells. Distributions of endogenous CD4+ 
and CD8+ T cells are presented in Figure 6-9. 
Investigation of the localization inside (CD45 double positive) or outside (CD45 single 
positive) of blood vessels (Figure 3-8C) revealed that stimulation of both -ARs led to a 
higher percentage of extravascular endogenous B cells in the liver (~15%), spleen 
(~10%) and spLNs (<1%), whereas only 2-AR stimulation had the same effect in the mLN 
(<1%). Their localization was not altered in the BM, lung and iLNs. Intra- and 










Figure 3-8: Endogenous B cell numbers decrease in blood and organs upon 
adrenergic stimulation. 
(A) Illustration of the experimental design. Recipient mice were intraperitoneally injected with 
PBS, Clenbuterol (Clen) or BRL37344 (BRL). At 12 pm, a CD45 labeling antibody was injected and 
blood was harvested 5 min later. Mice were perfused and organs were harvested and processed 
for flow cytometry. (B) Endogenous B cell numbers in blood and organs after injection of PBS or 
the specific agonists, extrapolated to 2 ml of blood or the whole organ, respectively. n = 5-39, one-
way ANOVA, Dunnett‘s test. (C) Intravascular (red) and extravascular (blue) endogenous B cells as 
percentage of the detected cells in the respective organs. n = 5-6, two-way ANOVA, Dunnett‘s test. 






Since endogenous B cell numbers were not significantly elevated in LNs, adoptively 
transferred donor B cells were investigated to focus on the impact of adrenergic 
stimulation on homing (Figure 3-9). Cells from the spleen and LNs were mixed and 
intravenously injected into WT mice that have received either PBS or the agonists at 
10 am. After one hour of circulation (at 12 pm), an antibody against CD45 was injected 
intravenously and blood was harvested five minutes later. Mice were perfused and one 
femur, the spleen, lung, liver and three LNs draining different areas were harvested. Data 
are presented as percentages of in total injected B cells. The fraction of donor B cells in 
blood was significantly reduced after BRL injection compared to PBS-treated mice, 
whereas after Clen injection cell percentages only showed a trend similar to endogenous 
cells (Figure 3-9B). Homing to the BM was not altered, while a higher percentage of 
transferred cells was found in the liver upon BRL treatment. Injection of Clen led to a 
decreased portion of donor B cells in the lung, indicating that B cell homing to the lung 
might be impaired. As mentioned above, endogenous B cell numbers were not 
significantly elevated in LNs and the spleen (Figure 3-9B). One possible reason could be 
that these tissues contain a massive amount of B cells already and about one million cells 
entering from the blood hardly made a significant difference. B cell homing to most of the 
tested secondary lymphoid organs was not affected by adrenergic stimulation (Figure 
3-9B). However, in the mLN, the percentage of donor B cells was significantly increased 
upon injection of Clen (~1%), suggesting an effect of adrenergic stimulation on B cell 
homing to LNs. Strikingly, other lymphoid cells were even more efficiently homing to the 
mLN (CD4+ T cells ~18% and CD8+ T cells ~23%, Figure 6-11). In general, it is important 
to mention that only a small fraction of the overall injected donor B cells (~15%) could be 
detected in the tested organs (Table 3-2), indicating that they either accumulated at the 
injection site or that the majority died. The distribution of other lymphoid donor cells is 
depicted in Figure 6-11. 
Regarding their localization inside or outside of blood vessels, 20% more donor B cells 
emigrated into the liver upon BRL treatment, therefore exhibiting the same behavior as 
endogenous cells in Figure 3-8C. This suggests preferred homing of endogenous as well 
as donor B cells to the liver upon administration of BRL. Compared to the control group, 
mLNs of Clen-stimulated mice possessed ~3.5% more intravascular donor B cells, 
indicating that these cells adhered to the vasculature in order to home to the tissue. Ratios 
of intra- and extravascular donor CD4+ and CD8+ T cells can be found in Figure 6-12. 
Summarized, B cells robustly left the circulation upon adrenergic stimulation and a small 







Figure 3-9: B cell homing might be affected by adrenergic stimulation.  
(A) Illustration of the experimental design. Recipient mice were intraperitoneally injected with 
PBS, Clenbuterol (Clen) or BRL37344 (BRL) and received 1hr later stained donor cells. At 12 pm, a 
CD45 labeling antibody was injected and blood was harvested 5 min later. Mice were perfused and 
organs were harvested and processed for flow cytometry. (B) Percentage of donor B cell from total 
injected B cells in blood and organs after injection of PBS or the specific agonists, extrapolated to 2 
ml of blood or the whole organ, respectively. n = 5-18, one-way ANOVA, Dunnett‘s test. (C) 
Intravascular (red) and extravascular (blue) donor B cells as percentage of the detected cells in the 
respective organs. n = 5-6, two-way ANOVA, Dunnett‘s test. iLN = inguinal lymph node, mLN = 






Table 3-2: Donor B cells as percentage of injected B cells in blood and organs. 
Data are presented as mean ± SEM. BM = bone marrow, iLN = inguinal lymph node, mLN = 
mesenteric lymph node, spLN = superficial parotid lymph node. 



























































3.5.2 B cell adhesion molecule levels change upon adrenergic stimulation 
To home to LNs, B cells require activation of various adhesion molecules and chemokine 
receptors, which interact with complementary receptors on ECs lining tissue blood 
vessels. To examine if surface levels of these molecules were altered upon adrenergic 
stimulation, mice were injected with PBS, Clen or BRL. Two hours later, at 12 pm, blood 
was harvested and MFIs of CXCR4, CD49d, CD62L, CD162 and CCR7 on B cells were 
recorded using flow cytometry (performed by Chen Wang).  
Compared to neutrophils, surface levels of more B cell intrinsic molecules were affected 
upon in vivo pharmacological stimulation. Treatment with both -AR agonists increased 
levels of CXCR4 and CD162 (two-fold) on circulating B cells, while CCR7 levels were 
significantly elevated only after Clen injection. CXCR4 and CCR7 are important chemokine 
receptors for lymphocyte homing to LNs, thus their upregulation supports the hypothesis 
of enhanced homing upon adrenergic stimulation, whereas CXCR4 also regulates B cell 
retention in the BM. Levels of CD62L were downregulated (two-fold) upon injection of 
Clen and BRL (Figure 3-10A), designating an activated state of B cells, as this adhesion 
molecule is shed upon activation and important for rolling of lymphocytes along HEVs in 
LNs. 
To test whether changes in surface molecule levels were caused by direct effects of 
adrenergic agonists on B cells, an in vitro assay was performed. Therefore, the spleen of 
WT mice was harvested at 12 pm, isolated cells were seeded into 96-well plates and 
stimulated with 1 mM of each agonist for two hours. In this approach, MFIs of CXCR4, 
CD49d, CD62L and CD11a were recorded. 
Figure 3-10B depicts a reduction of CD62L levels on B cells after in vitro incubation with 
Clen. In contrast to the in vivo approach, no changes were detected for the other tested 
molecules. Taken together, these data demonstrate that in vivo treatment with 
pharmacological agonists changed levels of adhesion molecules on the surface of B cells, 
corroborating an enhanced homing phenotype, whereby binding of agonists seemed to 






Figure 3-10: Adhesion molecule levels on B cells change upon adrenergic 
stimulation. 
(A) MFI of several molecules on circulating B cells after in vivo adrenergic stimulation. WT mice 
were intraperitoneally injected with PBS (gray), Clenbuterol (Clen, orange) or BRL37344 (BRL, 
yellow) 2hrs prior to blood harvest at 12 pm. n = 6, one-way ANOVA, Dunnett‘s test. Experiment 
was performed by Chen Wang. (B) MFI of several molecules on B cells after in vitro adrenergic 
stimulation. Spleens from WT mice were harvested and processed. Cells were seeded into 96-well 
plates and stimulated in vitro with PBS, Clen or BRL for 2hrs. n = 3, one-way ANOVA, Dunnett‘s test. 
MFI = Mean fluorescence intensity. 
 
 
3.5.3 Treatment with Clenbuterol impacts B cell trafficking through lymph nodes 
Since adrenergic stimulation altered levels of adhesion molecules mainly being involved 
in trafficking of B cells through LNs (Figure 3-10), it was investigated whether block of 
homing to these tissues attenuated or even abolished the phenotype observed in blood. 
First, LN homing was blocked using antibodies against the integrins CD49d and CD11a 
(see 2.1.11) with subsequent injection of PBS, Clen or BRL. Two hours later, at 12 pm, 
blood, skin-draining LNs (axillary, brachial, inguinal and popliteal) as well as one gut-
draining LN (mesenteric) were harvested and processed for flow cytometry. Data were 
normalized to untreated mice, which did not receive any stimulus (indicated by a black 
line). 
Shown in Figure 3-11A, B cell numbers in blood were elevated up to five-fold compared 




significant, Clen- and BRL-treated mice still exhibited slightly lower cell numbers in blood 
after the block. Besides a putative integrin-independent homing mechanism, reduced 
circulating numbers could also be attributed to the inability to re-enter the circulation. 
Indeed, enhanced retention was confirmed in pooled skin-draining LNs (sdLNs), where 
the fraction of B cells upon Clen administration was similar to the untreated group and 
increased (two-fold) compared to the PBS control. In the gut-draining mesenteric LN 
(gdLN), cell numbers were decreased compared to the untreated control, but there was 
no difference between PBS-treated and stimulated mice.  
 
Another molecule that was downregulated – or shed – by in vivo stimulation with 
adrenergic agonists was CD62L. As mentioned before, this molecule is important for 
rolling along HEVs in LNs. Thus, a blocking antibody was used (see 2.1.11), which was 
intraperitoneally injected 24 hours prior to harvest. As control, an isotype instead of the 
blocking antibody was administered. On the next day, mice received PBS or the 2- and 3-
AR agonist at 10 am. Two hours later, at 12 pm, blood was harvested and processed for 
flow cytometry. B cell numbers were normalized to the isotype control. LNs were not 
investigated in this experimental setup. 
Although B cell numbers in blood upon CD62L block of PBS-injected mice exhibited an 
almost ten-fold increase compared to the isotype control (black line), B cells of blocked 
and Clen- or BRL-stimulated mice still left the blood, ruling out the involvement of CD62L 
in the adrenergic-driven migratory behavior of B cells through LNs (Figure 3-11B).  
 
Previous studies demonstrated that stimulation of 2-ARs on lymphocytes leads to their 
retention in LNs (Nakai et al., 2014) and similar mechanisms could be assumed from 
homing block by inhibition of the integrins CD11a and CD49d (Figure 3-11A). Therefore, 
it was assessed whether block of LN egress by injection of FTY720 had a similar effect on 
B cell numbers in blood and LNs as adrenergic stimulation. FTY720 is a functional 
antagonist of S1PR1, a receptor crucial for lymphocyte egress from LNs (Mandala et al., 
2002). WT mice were first injected intraperitoneally with PBS or FTY720 (see 2.1.11) and 
directly afterwards with PBS, Clen or BRL. Two hours later, at 12 pm, blood, sdLNs and 
one gdLN were harvested and processed for flow cytometry. Data are shown as 
normalized to the group that received two consecutive injections of PBS (PBS+PBS). 
Blood of the PBS-injected control group showed the usual effects of adrenergic 
stimulation, namely decreased B cell numbers in the circulation upon injection of Clen and 
BRL (Figure 3-11C). Injection of FTY720 also resulted in decreased B cell numbers in 




Clen- and BRL-treated samples with preceding PBS injection (PBS+Clen and PBS+BRL) 
exhibited slightly reduced, but not significantly altered numbers. No additive effects were 
observed in the cohort receiving the egress blocker FTY720 prior to PBS or agonist 
administration. Egress block (FTY+PBS) should have led to increased lymphocyte 
numbers in LNs, however, the treatment was performed just shortly before the harvest 
(two hours), so this time frame was possibly not sufficient for B cells to accumulate to a 
measurable extent in the investigated LNs. In the gdLN, FTY720 treatment in combination 
with PBS administration (FTY+PBS) showed slightly increased cell numbers, whereas 
there was no difference detectable to the stimulated groups (FTY+Clen and FTY+BRL). 
Thus, it is not clear whether FTY720 and pharmacological agonists have similar effects on 
B cell retention in the LN. Further experiments will be necessary to elucidate the effect of 
adrenergic stimulation on homing and egress of B cells. The impact of egress block on 
other leukocyte subsets can be found in Figure 6-14. 
To investigate the influence of adrenergic stimulation, particularly mediated by 2-ARs, 
on the migration behavior of B cells in vivo, intravital imaging of B cells in the vasculature 
of the popliteal LN (popLN) was performed. After surgical exposure of the popLN of 
anaesthetized mice, unstimulated B cells in superficial blood vessels were imaged for 
about 15 minutes to ensure altered adhesion profiles were not trauma-induced. At 10 am 
(the usual time for in vivo treatments), either PBS or Clen were injected intraperitoneally 
and the same vessels were imaged (see 2.1.13). The MFI inside of blood vessels was 
measured and normalized to the MFI of control videos. In the sum projection of the imaged 
z-stacks over time, rolling or circulating cells were excluded (analysis by Dr. Robert Pick). 
The graph in Figure 3-11D depicts the relative adhesion of B cells for a time frame of three 
minutes after injection of PBS or Clen. Initial adhesion in vessels of the popLN was slightly 
higher in Clen-treated mice, rising steeper after two minutes. Afterwards, relative 
adhesion decreased again. This behavior indicates that B cell adhesion, if only transiently, 






Figure 3-11: The migratory behavior of B cells is affected by adrenergic stimulation. 
(A) Fraction of B cells in blood and LNs after neutralization of CD49d and CD11a combined with 
adrenergic stimulation. WT mice were intraperitoneally injected with blocking antibodies and 
directly afterwards with PBS, Clenbuterol (Clen) or BRL37344 (BRL). At 12 pm, blood and LNs 
were harvested and processed for flow cytometry. Data are shown as normalized to the untreated 
group not receiving any stimulus (black line). n = 6, one-way ANOVA, Dunnett‘s test. (B) Fraction 
of B cells after CD62L block combined with adrenergic stimulation. WT mice were either 
intraperitoneally injected with a blocking antibody against CD62L or the respective isotype 24hrs 
prior to injection of PBS, Clen or BRL at 10 am. Blood was harvested at 12 pm. Data are shown as 
normalized to the isotype control (black line). n = 3, one-way ANOVA, Dunnett‘s test. (C) Fraction 
of B cells in blood and LNs after egress block and adrenergic stimulation. At 10 am, WT mice were 
intraperitoneally injected with PBS or FTY720 and directly afterwards with PBS, Clen or BRL. At 
12 pm blood and LNs were harvested and processed for flow cytometry. n = 3, two-way ANOVA, 
Tukey‘s test, stars indicate comparison to PBS+PBS group. (D) Relative adhesion of B cells in the 
superficial vasculature of the popLN after PBS or Clen injection and representative image. B cells 
in LN vessels were imaged for 15 min before PBS or Clen were injected and the same vessels were 
imaged. Relative adhesion over time is shown as percentage normalized to the control video 
(analysis by Dr. Robert Pick). Scale bar = 50 µm, n = 2, unpaired t-test, Mann-Whitney‘s test. sdLN = 





3.5.4 The adrenergic influence on B cells is 2-AR-specific 
So far, adrenergic stimulation led to a reduction of endogenous B cell numbers in blood, 
BM, liver and lung. To investigate whether B cell-intrinsic or -extrinsic 2-ARs were 
responsible for the phenotype in the majority of tested organs, a reciprocal adoptive 
transfer was performed with this leukocyte subset. WT or Adrb2 KO donor cells were 
transferred to PBS- or Clen-treated WT recipients, or WT donor cells were transferred to 
treated WT or Adrb2 KO mice. After one hour of circulation, blood was harvested at 12 pm. 
Mice were perfused and organs were harvested for flow cytometric analysis (Figure 
3-12A).   
First, endogenous B cell numbers in WT and Adrb2 KO mice stimulated with PBS or Clen 
were examined (Figure 3-12B). In blood of WT mice, results from previous experiments 
(Figure 3-8B) could be reproduced, showing a two-fold decrease in cell numbers upon 
Clen administration. As this was not the case in Clen-stimulated mice lacking the target 
receptors, effects observed in blood were confirmed to be specific for 2-ARs. No changes 
were expected and assessed for endogenous B cell numbers in BM and spleen of WT mice. 
Interestingly, B cells were accumulated in the spleen of Adrb2 KO recipients, indicating 
that 2-ARs might play a role in B cell homing to or retention in this organ. Upon Clen 
injection in previous experiments, B cells left the liver (Figure 3-8B), and the same trend 
was observed in WT recipients (Figure 3-12B). In the lung, lower numbers were expected 
as well, but could not be confirmed, indicating that – similar to neutrophils – the B cell 
phenotype in this organ was unspecific. Similar to the spleen, endogenous cell numbers in 
the lung of Adrb2 KO mice were higher than in WT controls. Thus, this experiment 
demonstrated that effects of Clen on endogenous B cells were 2-AR specific. 
After confirming its specificity, it was tested which cell type was the main target of Clen 
or if, alike neutrophils, leukocytes and their microenvironment were involved. Therefore, 
WT or Adrb2 KO donor cells were transferred to PBS- or Clen-treated WT recipients 
(Figure 3-12C).  In general, no significant changes between WT and Adrb2 KO donor B 
cells were detected, indicating that B cell intrinsic 2-ARs did not play a major role in the 
changed migration behavior. According to previous results (Figure 3-9B), reduced 
homing of WT donor cells to WT lungs was expected, which could not be reproduced.  
The same applied for the fraction of WT donor B cells in PBS- or Clen-stimulated WT or 
Adrb2 KO recipients (Figure 3-12D). Taken together, B cells left the blood stream upon 
specific stimulation of 2-ARs, but, despite the robust phenotype, lack of 2-ARs on either 




B cells or their microenvironment – or both – are targets of pharmacological stimulation 




Figure 3-12: The adrenergic influence on B cells is 2-AR-specific. 
(A) Illustration of the experimental design. WT or Adrb2KO mice were injected with PBS (gray) or 
Clenbuterol (Clen, orange) and received 1hr later mixed WT and Adrb2KO donor cells. Another 
hour later, at 12 pm, blood was harvested, mice were perfused and organs were harvested for flow 
cytometry. (B) Endogenous B cell numbers in blood and organs of PBS- or Clen-injected recipients. 
Cell counts were extrapolated to 2 ml of blood or the whole organ. n = 6, two-way ANOVA, Sidak‘s 
test. (C) Fraction of WT or Adrb2KO donor B cells in blood and organs of WT recipients, normalized 
to WT donor cells in the PBS-injected control. n = 6, two-way ANOVA, Sidak‘s test. (D) Fraction of 
WT donor B cells in PBS- or Clen-treated WT or Adrb2KO recipients. n = 6, two-way ANOVA, Sidak‘s 





For neutrophils it was difficult to interpret whether the pharmacological agonist BRL 
targeted 3-ARs specifically (Figure 3-7D). The same approach was performed for B cells, 
which were examined in a reciprocal adoptive transfer between WT and Adrb3 KO mice. 
WT or Adrb3 KO donor cells were injected into PBS- or BRL-treated WT recipients, or WT 
donor cells were transferred to treated WT or Adrb3 KO recipients. At 12 pm, blood was 
harvested and recipients were perfused. Subsequently, four organs were harvested and 
processed together with blood for flow cytometry (Figure 3-13A).  
For endogenous B cell numbers in blood of WT recipients, a dramatic reduction was 
expected upon BRL injection, according to previous results (Figure 3-8B). This held true 
for WT recipients, but also for recipients lacking 3-ARs (Figure 3-13B), corroborating 
that the observed effects in blood were most likely not mediated through 3-ARs, but due 
to unspecific effects of BRL, potentially due to binding to other -ARs (Mori et al., 2010). 
In BM, only BRL showed an effect for endogenous B cell numbers in Figure 3-8B, which 
could indicate that in this organ BRL acted specifically. Slightly reduced numbers were 
found in BRL-injected WT recipients, with higher numbers of B cells in the BM of Adrb3 
KO mice (Figure 3-13B), suggesting that 3-ARs could be involved in B cell mobilization 
from this tissue. In contrast to results in Figure 3-8B, changes in B cell numbers in the 
liver were detected, however, this could have been caused by unspecific binding. In the 
lung, results were difficult to interpret due to the high deviation in the PBS-treated 
controls.  
WT and Adrb3 KO donor B cells exhibited extreme differences in their distribution to 
blood, BM and the spleen of WT mice (Figure 3-13C). Donor B cells lacking 3-ARs did not 
leave the blood, but homed more efficiently to the BM (15-fold) and spleen (ten-fold) as 
well, indicating that 3-ARs could be important in these tissue-specific processes. In 
contrast, no significant changes were observable in the liver and lung (because of a high 
deviation between samples). Moreover, no differences were detected between PBS- and 
BRL-treated Adrb3 KO mice. 
After transferring WT donor B cells into stimulated WT or Adrb3 KO mice, no significant 
differences were discovered (Figure 3-13D), although donor numbers in blood of both 
recipients were slightly reduced upon BRL administration.  
Summarized, the role of 3-ARs in altered B cell migration behavior remains elusive, 
especially since BRL obviously had off-target effects, potentially on 2-ARs (Mori et al., 
2010). Hence, the reduction of B cells in the circulation was probably mediated by 2-ARs 






Figure 3-13: 3-ARs are not involved in the reduction of circulating B cells. 
(A) Illustration of the experimental design. WT or Adrb3KO mice were injected with PBS (gray) or 
BRL37344 (BRL, yellow) and received 1hr later mixed WT and Adrb3KO donor cells. Another hour 
later, at 12 pm, blood was harvested, mice were perfused and organs were harvested for flow 
cytometry. (B) Endogenous B cell numbers in blood and organs of PBS- or BRL-injected recipients. 
Cell counts were extrapolated to 2 ml of blood or the whole organ. n = 6, two-way ANOVA, Sidak‘s 
test. (C) Fraction of WT or Adrb3KO donor B cells in blood and organs of WT recipients, normalized 
to WT donor B cells in the PBS-injected control. n = 6, two-way ANOVA, Sidak‘s test. (D) Fraction 
of WT donor B cells in PBS- or BRL-treated WT or Adrb3KO recipients. n = 6, two-way ANOVA, 





 Discussion and Conclusion 
 
Interactions between the immune system and the nervous system have been a topic of 
interest for several decades. However, despite a plethora of publications, the intricate 
interplay between these two crucial systems remains elusive. This is due to the difficult 
dissection of complex dynamics between multiple cellular and molecular elements in 
various organs. In this study, I focused on the influence of -AR activation on the in vivo 
distribution of neutrophils and B cells. Adoptive transfer experiments and flow cytometric 
analyses demonstrated differing effects of 2-AR stimulation on both leukocyte subsets. In 
the course of this chapter, findings will be discussed and integrated into the current 
knowledge about adrenergic control of leukocyte trafficking.   
 
4.1 The disparity between stimulation and block 
 
The agonist Isoproterenol unselectively binds to -ARs and activates the same pathways 
as endogenous ligands such as norepinephrine. Thus, it was hypothesized that enhanced 
activation of these receptors could trigger intracellular signaling pathways resulting in 
modulation of the migratory properties of leukocytes. As a matter of fact, neutrophil 
numbers in blood robustly increased, whereas B cell numbers were diminished, and this 
occurred already after a short-term incubation time of two hours. However, it is important 
to keep in mind that Isoproterenol acts in addition to the already existing catecholamines 
in blood. Their levels vary over the course of a day, according to phases of activity and 
rest. For mice, the night equals the phase of activity and catecholamine levels in plasma 
are higher compared to the rest phase during the day (De Boer and Van der Gugten, 1987). 
In contrast, for humans whose active phase is during the day, plasma levels are inversed 
(Linsell et al., 1985). Hence, exogenous stimulants can have varying effects depending on 
the time point of administration and sensitivity of the system to stimulation. In this study, 
12 pm and 8 pm were chosen for harvest, as these times reflect the peak and trough of 
leukocyte concentrations in murine blood (Druzd et al., 2017; He et al., 2018; Scheiermann 
et al., 2012). The fact that neutrophil numbers were increased after Isoproterenol 
administration at both time points suggests that enhancement of  -AR stimulation with 
the used dosage has the same effect, regardless of endogenous plasma catecholamine 
levels. Circulating B cell numbers were only decreased after Isoproterenol injection 




it is unclear whether this is due to different endogenous catecholamine levels. To date, 
knowledge on concentration of catecholamines in various tissues is limited. In order to 
elucidate effects of neurotransmitters on the migratory behavior of immune cells, a 
detailed map is necessary, stating concentrations of substances such as norepinephrine in 
various body parts, ideally under both steady state and different inflammatory scenarios. 
While quantification of catecholamine levels in body fluids is commonly performed, tests 
in organs are more challenging, since structural features of catecholamines are present in 
a variety of other biomolecules as well. Detection methods in living cells have been 
established (Tong et al., 2019), but are difficult to use in complex biological environments. 
Thus, sophisticated detection methods are required such as it was used to measure 
norepinephrine levels in different compartments of the rat heart (Novotny et al., 2007).  
Administration of the pan--AR antagonist Propranolol blocks signaling cascades by 
competitive binding of the substance to -ARs (Al-Majed et al., 2017a). Hence, endogenous 
ligands of adrenergic receptors are hindered to bind, leading to the hypothesis that 
circulating leukocyte numbers might change compared to the PBS control. However, only 
slight effects of the unselective antagonist were observed for both subsets, regardless of 
the time of administration. The fact that injection of Propranolol did not show dramatic 
effects could have multiple reasons. Effects could be dose dependent; thus, it would be 
useful to test different concentrations of the blocker. -AR density also changes depending 
on desensitization processes (at least for 1- and 2-ARs(Nantel et al., 1993)), which is 
difficult to test in vivo. Furthermore, levels of -ARs on the cell surface vary in a cell type-
specific and maturation-dependent manner (Elenkov et al., 2000). Importantly, it was 
shown that Propranolol exhibits a much lower affinity for 3-ARs in comparison to 1- and 
2-ARs (Cernecka et al., 2014), which could explain the weaker phenotype compared to 
agonism targeting all -AR subtypes. Although Propranolol does not show 
sympathomimetic effects (Al-Majed et al., 2017a), it is also not known whether other 
intracellular mechanisms are activated (called partial agonism). To elucidate this, it would 
be necessary to perform phospho-proteomic analyses of cells stimulated with the pan--
AR agonist and antagonist. Since Propranolol only blocks -ARs, signaling of -ARs is 
unaffected and could therefore exhibit influences on leukocyte distributions as well, such 
as it was shown for long-term stimulation with respective agonists (Stevenson et al., 
2001).  
To investigate whether absence of sympathetic tone influenced circulating leukocyte 
numbers, chemical sympathectomy using the neurotoxin 6-OHDA was performed. This 




peripheral nerve terminals, where it damages these structures via generation of ROS and 
interactions with the mitochondrial respiratory chain (Rodriguez-Pallares et al., 2007). 
Thus, signals from peripheral nerves are ablated upon repeated administration of 6-
OHDA. However, the absence of peripheral nerve signals did not alter circulating 
neutrophil and B cell numbers. This could be explained by a putative compensatory effect 
of epinephrine, which is derived from the adrenal cortex to be systemically released into 
the blood stream and correspondingly was not target of the chemical sympathectomy. 
Therefore, it will be useful to test the impact of epinephrine absence on circulating 
leukocyte numbers, for which mice can be adrenalectomized. In addition, it could be 
tested whether exogenous norepinephrine and epinephrine can rescue effects of 
combined sympathetic ablation and adrenalectomy on circulating leukocyte numbers. 
Furthermore, use of 6-OHDA systemically ablates neural signals. Knowing that loss of local 
adrenergic innervation leads to defects of circadian leukocyte adhesion and emigration in 
the BM and cremaster muscle in a time-of-day-dependent manner (Scheiermann et al., 
2012), it would be of interest which specific subsets are dependent on locally delivered 
signals. Removal of the superior cervical ganglion innervating the cranial BM could help 
to investigate the effects of the local adrenergic tone on neutrophil mobilization from this 
tissue. However, since the most robust readout in this thesis is the blood, it will be difficult 
to investigate local blood compartments. Further sources for catecholamines should also 
be regarded, such as the leukocyte subsets T cells (Rosas-Ballina et al., 2011) and 
macrophages (Flierl et al., 2007), which might have an impact on the local catecholamine 
milieu, depending on e.g. their activation mechanisms (Fischer et al., 2017).  
 
4.2 The specificity issue with pharmacological agonists 
 
Next, it was tested which specific -ARs were involved in the effects of adrenergic 
stimulation by Isoproterenol. For this, the 1-AR targeting agonist Denopamine, the 2-AR 
agonist Clenbuterol and the 3-AR agonist BRL37344 were injected. Whereas 
Denopamine did not alter leukocyte subset numbers in blood, Clenbuterol and BRL37344 
reproduced the effects of Isoproterenol, which led to the conclusion that 2- and 3-ARs 
are involved in the control of leukocyte trafficking. Later in this study, use of mice lacking 
3-ARs revealed, however, that BRL37344-induced effects were not specific for this 
particular receptor type, suggesting that other adrenoceptors such as -ARs were 
targeted (Mori et al., 2010; Pott et al., 2003). As a consequence, the same effects should 




observations are most likely mediated by 2-ARs. In contrast, in other organs such as the 
BM, only BRL37344 administration affected neutrophil and B cell numbers. Using Adrb3 
KO mice, a previous study reported that non-hematopoietic 3-ARs in the BM are involved 
in the circadian leukocyte recruitment to this tissue (Scheiermann et al., 2012). Hence, 
BRL37344 could target 3-ARs specifically in this tissue, potentially as a function of 
surface receptor density, which is relatively high in the BM during the day, whereas at 
night 2-ARs prevail (Garcia-Garcia et al., 2019). For interpretation of data obtained with 
this agonist further investigation is required, e.g. by injection of BRL37344 into mice 
lacking other -ARs or in vitro binding assays, where the compound competes with a 
standard radioligand with high affinity for available receptor sites on leukocytes and cells 
of their microenvironment. Taken together, when investigating the interplay between 
neural signals and immune cells, numerous challenges have to be considered. From a 
plethora of previous studies, it is clear that this relationship is extremely dynamic, with 
respect to its dependence on the examined cell types, the maturation and activation state 
of these cells, the inflammatory milieu as well as evidently trivial aspects such as the time 
of agonist exposure (Elenkov et al., 2000). Regarding the latter, it was tested what time 
was best for analysis after administration of the specific agonists. In conformity with 
previous reports (Nakai et al., 2014), in blood two hours of stimulation showed the 
greatest differences from leukocyte numbers in the control group (exemplarily shown for 
B cells), but already after one hour, B cell numbers were reduced. Circulating B cell 
numbers normalized to initial levels after six hours after injection, suggesting that 
agonists were metabolized until then. Thus, acute (within two hours) impacts of 
adrenergic stimulation were examined for more insight into direct effects of leukocyte 
distributions. Moreover, it was tested whether diminished B cell numbers in the 
circulation were caused by enhanced cell death, as it was shown for prolonged treatment 
with -AR agonists (Stevenson et al., 2001). This was not the case, neither after in vivo nor 
after in vitro treatment of B cells with both -AR agonists. 
 
It is known that the SNS – together with the hypothalamic pituitary axis (HPA) – plays a 
role in inflammation, known as the inflammatory reflex. When local inflammation is 
detected by fibers of sensory and vagal nerves, signals are transmitted to the CNS, which 
leads to activation of the SNS. Release of neurotransmitters at the site of inflammation can 
have a complex outcome challenging the previous speculation, that activity of the SNS 
might be generally anti-inflammatory (Pongratz and Straub, 2014). To investigate the 
impact of adrenergic stimulation on leukocyte migration in an inflammatory scenario, 




displaying a similar trend to the steady state – increased neutrophil and decreased B cell 
numbers in blood – effects were not as profound. This could be explained by lower B cell 
numbers upon TNF administration, however, neutrophil numbers were similarly high 
compared to the steady state. Another possibility could be a putative effect of TNF on the 
responsiveness of -ARs. Whereas -ARs are capable of regulating LPS-induced TNF 
secretion (Elenkov et al., 1995), a potential inverted effect is much more intricate, since 
expression of adrenoceptors on leukocytes is dynamic and depends on the cellular 
differentiation and activation state, as well as the regulation by catecholamine levels, 
which vary during an immune response (Elenkov et al., 2000). Hence, in order to examine 
and compare effects of adrenergic stimulation on leukocyte trafficking during 
inflammation, future studies will have to focus on distinct inflammatory models.  
 
4.3 Diverse effects on innate and adaptive immune cells 
 
Trafficking of neutrophils and B cells through a variety of vital organs was investigated. 
Since these two leukocyte subsets are important representatives of the innate and 
adaptive immunity, respectively, it is important to understand how they are influenced by 
adrenergic signals. As shown in multiple experimental setups utilizing pharmacological 
agonists and KO mice, impacts of adrenergic stimulation on these cell types differed 
greatly. In blood, neutrophil numbers were elevated, whereas B cell numbers declined, 
coinciding with other studies (Dhabhar et al., 2012; Nakai et al., 2014). Mechanisms 
leading to altered circulating numbers are enhanced mobilization or impaired 
recruitment/homing. On the other hand, decreased numbers result from impaired 
mobilization, enhanced recruitment/homing or perturbed recirculation. In the following 
paragraph, a possible adrenergic influence on these parameters will be discussed. 
 
4.3.1 Are neutrophils mobilized from the BM? 
Signals from the SNS were shown to control leukocyte egress from the BM (Mendez-Ferrer 
et al., 2008), albeit the process being rather complicated due to interaction of various 
components at specific times of the day. Here, BRL37344 injection led to decreased 
neutrophil numbers in BM and increased numbers in blood during the day (12 pm). 
However, – as mentioned above – data obtained with this adrenergic agonist have to be 




BM egress under stress situations could lead to release of premature cells, which can be 
tested by staining of maturation markers, such as CXCR2 (Evrard et al., 2018). Another 
marker for neutrophil maturation is CXCR4, which is upregulated on immature 
neutrophils (Evrard et al., 2018). Examination of molecule levels on neutrophils after in 
vivo stimulation with the 2-AR agonist revealed slightly upregulated CXCR4 levels, 
supporting the hypothesis that neutrophils might be prematurely released into the 
circulation upon adrenergic stimulation. Mobilization of neutrophils from the BM benefits 
the organism during inflammation, since these cells are ready to be recruited to sites 
where their presence is required. Thus, this readout is used as diagnostic marker at the 
onset of various diseases, such as recently shown for severe COVID-19 (Carissimo et al., 
2020). If stress persistently upregulates numbers of immature neutrophils in the 
circulation, this could mark disease-related effects.  
To clarify whether neutrophils really are increased due to enhanced mobilization and no 
other mechanisms such as demargination from the lung (Devi et al., 2013), proliferation 
assays using the synthetic nucleoside bromodeoxyuridine (BrdU) could be utilized to 
identify and quantify newly proliferating neutrophils in the circulation after -AR 
stimulation. Contradicting enhanced demargination, neutrophil numbers were elevated 
in the perfused liver and lung. Although for human granulocytes it was demonstrated in 
vitro that catecholamine-induced cellular softening leads to demargination (Fay et al., 
2016), this might not be the case in the murine in vivo experimental procedure used here. 
 
4.3.2 Is neutrophil recruitment from blood impaired? 
Upon 2-AR stimulation via Clenbuterol administration, neutrophil numbers in blood 
were elevated at both time points tested (12 pm and 8 pm). After adoptive transfer of 
exogenous neutrophils, these cells were captured in the circulation, probably due to 
impeded recruitment from blood, which was found to be mediated by 2-ARs. In order to 
be recruited to sites of inflammation or tissue damage, neutrophils utilize certain 
adhesion molecules and chemokine receptors, whose requirement differs between 
vascular beds. One of these molecules is CD62L, which mediates neutrophil rolling along 
the endothelial barrier in the majority of organs. Although not significant, CD62L levels 
increased upon Clenbuterol administration, indicating a less activated state (since this 
molecule is shed upon activation) that could explain retention in the circulation. This 
change in CD62L levels is in contrast to a study where expression on neutrophils 




which are both binding to 2-ARs, albeit with different affinities (epinephrine binds more 
potently to 2-ARs than norepinephrine (Liapakis et al., 2004)). Further evidence for a 
reduced recruitment is provided by decreased CD49d levels, which is part of the integrin 
complex VLA-4 facilitating neutrophil adhesion to ECs. However, integrin levels are not as 
meaningful as their activity state, since binding affinities are able to change without 
alterations in surface levels of these molecules (Schürpf and Springer, 2011). Moreover, 
although levels of integrins were not affected by adrenergic stimulation, levels of their 
binding partners such as ICAM-1 could be altered, which were not tested in the course of 
this work. 
If BRL37344 targeted both adrenoceptors simultaneously (Mori et al., 2010; Pott et al., 
2003), circulating neutrophil numbers should have exceeded neutrophil numbers in 
blood from Clenbuterol-stimulated mice (due to impaired recruitment and additional 
egress from the BM). This could have been compensated by their migration to other 
organs, such as the liver, which exhibited six-fold elevated neutrophil numbers upon 
BRL37344 administration. An already specified possibility to test putative off-target 
effects is administration of BRL37344 to mice lacking 2-ARs. Although this approach will 
not demonstrate the extent to which this compound binds both -ARs, it will clarify 
whether 2-ARs are involved in results obtained with the reputed 3-AR specific agonist. 
 
4.3.3 How is neutrophil homing to the BM affected? 
Next to BM egress -ARs – mainly 3-ARs of non-hematopoietic origin – were shown to 
mediate leukocyte homing to the BM at night (Scheiermann et al., 2012). Thus, stimulation 
of these receptors should have led to decreased neutrophil numbers in blood and 
increased numbers in BM. In contrast, using adoptively transferred cells, their 
accumulation in the circulation was demonstrated after recipient injection with 
Clenbuterol or BRL37344, although experiments were performed during the day. In 
addition, donor neutrophils did not exhibit enhanced migration to the BM upon 
Clenbuterol and BRL37344 administration. To investigate if adrenergic stimulation 
disrupts or promotes neutrophil homing in a time-of-day-dependent manner, adoptive 
transfers should be performed at night as well – when the magnitude of homing to the BM 
is greater than during the day.  
While CXCR4 is important for leukocyte retention in BM, its upregulation is also a signal 




Thus, adrenergic signal-mediated upregulation of CXCR4 in the in vivo setup indicates 
neutrophil migration back to the BM. In this case, adrenergic stimulation in the tested time 
frame was potentially too short to promote homing in the extent of measurable 
differences in neutrophil numbers in the BM, but the process could have been initialized, 
i.e. by upregulation of CXCR4 on the surface of neutrophils. Moreover, altered CXCR4 
levels can be interpreted one way or the other – as levels are upregulated on immature 
neutrophils as well as senescent neutrophils – complicating a conclusion of adrenergic 
effects on neutrophil migration behavior. In this respect, administration of BrdU could 
help to identify the age of neutrophils under investigation. Hence, more detailed 
experiments are required to unravel the molecular machinery leading to the observed 
phenotypes. Besides, only molecules on neutrophils have been tested, but reciprocal 
adoptive transfers revealed a role for non-hematopoietic cells, in accordance to other 
studies (Scheiermann et al., 2012). Thus, adhesion molecules on e.g. ECs of organs of 
interest should be tested after administration of Clenbuterol and a more reliable 3-AR 
specific agonist. Provided that a previous work reported enhanced levels of E-selectin, P-
selectin and VCAM-1 in BM after stimulation with Isoproterenol at night (Scheiermann et 
al., 2012), future investigations should focus on these molecules. Generation of EC lineage-
specific Adrb KO mice would help to specify the influence of this important environmental 
component. 
 
4.3.4 How does the SNS orchestrate neutrophil distributions? 
As discussed above, neutrophil migration between several organs at different times of the 
day is a delicate process. The interplay between adrenergic signal-driven egress and 
homing to the BM was recently reported to be time-sensitively coordinated by the 
cholinergic nervous system that downregulates 2-ARs during the day, resulting in egress 
via 3-ARs, while at night, 2-ARs prevail and facilitate leukocyte homing to the BM 
(Garcia-Garcia et al., 2019). To add a level of complexity, effects of adrenergic agonists are 
highly dependent on the cellular maturation and activation state. Thus, discrepancies 
between different studies could be based on the fact that only cell types were identified 
rather than other features, such as age or activation state. In the course of their life time 
in the circulation, neutrophils change their properties following a circadian rhythm 
(Adrover et al., 2019). Since knowledge about neutrophil heterogeneity is evolving (Ng et 
al., 2019), it will be important to further phenotype cells of this subset for a more detailed 




revealed a role of 2-ARs on the neutrophil as well as the microenvironmental side, 
lineage-specific Adrb2 KO mice would give more insight into the interplay between these 
two components.  
 
4.3.5 How does the SNS impact B cell trafficking through LNs? 
B cells constantly recirculate through secondary lymphoid organs in surveillance of 
antigen. They enter LNs via HEVs and migrate within these tissues to distinct follicles. If 
they do not encounter their cognate antigen, they egress into the lymph and back to the 
blood stream. Egress from LNs is orchestrated by an interplay between exit-promoting 
factors such as S1PR1 and retention-promoting factors such as the chemokine receptor 
CCR7 (Pham et al., 2008). Accordingly, examination of CCR7 levels on circulating B cells 
upon 2-AR stimulation revealed an increase of this molecule. In addition, B cell numbers 
in skin-draining LNs were elevated despite homing block, further suggesting a retention-
promoting effect of 2-AR stimulation. These data are in line with other studies, where 
enhanced retention in LNs was attributed to physical interactions between 2-ARs and the 
chemokine receptors CXCR4 and CCR7 (Nakai et al., 2014). However, homing was 
neglected in that report, whereas adoptively transferred B cells in this study were found 
to preferentially migrate to the mLN, although they were injected just one hour prior to 
harvest, indicating a slightly augmented homing of B cells to LNs due to 2-AR stimulation. 
Moreover, intravital imaging of B cells in the vasculature of popLNs revealed an altered 
adhesion capacity upon administration of Clenbuterol. Considering these data, it is 
possible that integrins are involved in enhanced homing to LNs. Therefore, levels of 
adhesion molecules on the surface of B cells were tested. Since integrin levels did not 
change, but blocking of these molecules with antibodies impacted the migratory behavior 
of B cells, it is hypothesized that integrin affinity might be controlled by 2-ARs. This could 
be tested using affinity binding assays with soluble ICAM-1 (the ligand of these integrins).  
Whereas homing of adoptively transferred B cells to the mLN was increased upon 
Clenbuterol administration, homing block demonstrated B cell retention merely in sdLNs 
and not the gut-draining mLN. What causes this inconsistency? First, cellular contents of 
LNs are dependent on the tissue size, which differs between LNs as well as between mice. 
Second, molecular requirements for homing vary between certain LNs. In HEVs of gut-
associated lymphoid tissue (GALT) such as the mLN, MADCAM-1 is highly expressed 
(Streeter et al., 1988). Its binding partner VLA-4 (which partly consists of CD49d) was 




Habtezion et al., 2016). Since it is hypothesized that integrin affinity might be controlled 
by 2-ARs, administration of Clenbuterol could increase CD49d affinity and therefor 
enhance donor B cell homing to mLNs. This could also explain why block of CD49d and 
CD11a (homing block) led to lower B cell numbers in the mLN, whereas numbers of B cells 
were still elevated in sdLNs of Clenbuterol-stimulated mice. Thus, the mLN should be in 
the center of future investigations addressing adrenergic control of B cell trafficking.  
Strikingly, CD62L levels on B cells were dramatically reduced upon adrenergic stimulation 
– in vivo and in vitro – pointing to an enhanced activity of the cells, since this molecule is 
shed upon activation. Similar results were obtained by others, whereby corticosterone 
outrivaled norepinephrine and epinephrine in its effects (Dhabhar et al., 2012). Given that 
this molecule is important for lymphocyte homing to LNs (He et al., 2018; Rosen, 2004), it 
was expected that block of CD62L would increase circulating and diminish B cell numbers 
in LNs. Surprisingly, no effect was observed in blood, disproving a role of this molecule in 
adrenergic redistribution of this lymphocyte subset. However, the blocking antibody 
reacts with CD62L and it is not clear whether there is still a certain capacity to shed the 
molecule. Mice lacking CD62L will give more insight into its involvement in lymphocyte 
redistribution. Other affected molecules were CXCR4 and CD162 (PSGL-1). To unravel 
their importance in the observed phenotype, further blocking experiments are required.  
After observing increased CD62L levels upon in vitro stimulation of B cells with 
Clenbuterol, it was hypothesized that cell-intrinsic 2-ARs are crucial for the observed 
effects. In addition, others already showed a cell-autonomous effect of adrenergic signals 
on the trafficking of lymphocytes through LNs (Nakai et al., 2014). However, no 
interpretation could be provided, since donor cells in the control did not behave as 





Is it possible to transfer effects of adrenergic stimulation on leukocyte trafficking from 
mouse to human? As catecholamine levels oscillate in both species, but with inverted 
rhythms (De Boer and Van der Gugten, 1987; Linsell et al., 1985), it seems likely that 
comparable mechanisms might occur. Of course, several differences have to be considered 




affinities of adrenergic agonists between species (Nahmias et al., 1991). Moreover, 
receptor function on human leukocytes can vary between healthy subjects and subjects 
suffering from medical conditions such as hypertension (Feldmann et al., 1984). Whereas 
in mouse models multiple stress situations are experimentally mimicked, by e.g. 
manipulation of housing temperatures (Hylander et al., 2019), investigations of the 
interplay between the immune system and nervous system in humans are mostly limited 
to blood examinations during physical activity or psychological stress situations, such as 
public speaking (Goebel and Mills, 2000). However, it is important to take into account 
that different stressors can have different outcomes – in both species (Bowers et al., 
2008). 
 
Since leukocyte trafficking is essential for every aspect of a functioning immune system, 
leukocyte redistribution under control of adrenergic input might be capable of 
manipulating immune responses. Indeed, it was recently shown that during the active 
phase of mice, higher responses in LNs are achieved, such as an elevated magnitude of 
antibody production (Suzuki et al., 2016). If this is transferable to humans, vaccination 
efficiency might be improved by combination with low doses of adrenergic agonists at the 
appropriate time of the day. In addition to adaptive immune responses, the innate immune 
system profits from stimulation of -ARs, evidenced by improved survival of lethally 
irradiated mice (Scheiermann et al., 2012). Thus, application of adrenergic agonists could 
open possibilities to improve BM transplantations, although repeated doses will be 
necessary and possible side effects have to be monitored frequently. 
In this study it was shown that stimulation of -ARs massively influences circulating 
leukocyte numbers in mice. Therefore, this system provides certain potential for 
therapeutic treatments of diseases where the immune system is involved. To date, mostly 
-AR blockers such as Propranolol are clinically used to treat cardiovascular diseases (do 
Vale et al., 2019), whereas adrenergic agonists are predominantly used for acute 
treatments of e.g. allergic asthma. While their mode of action targets smooth muscle cells 
of the vasculature to achieve bronchorelaxation, effects on the immune system might have 
been underestimated in these scenarios, especially in the context of prolonged treatments. 
Taken together, to reduce negative side effects of currently used and future drugs, it will 
be important to elucidate possible outcomes of -AR modulation on leukocyte behavior 






4.5 Concluding remarks 
 
In this work, first steps have been undertaken to disentangle impacts of the sympathetic 
nervous system – via -ARs – on the trafficking of neutrophils and B cells under steady-
state conditions. Using experimental procedures such as adoptive transfers and intravital 
microscopy, it was demonstrated that neutrophil numbers in the circulation are increased 
by an interplay between enhanced mobilization and impaired recruitment. In contrast, B 
cells left the blood stream and migrated to LNs, where they were retained and thus 
hindered to reenter the circulation. Using reciprocal adoptive transfers between WT and 
genetically modified mice lacking 2- and 3-ARs, most of these observations were 
attributed to stimulation of hematopoietic and non-hematopoietic 2-ARs, which directly 
or indirectly altered adhesion molecule levels on leukocytes. Additionally, BRL37344 was 
identified as nonspecific for 3-ARs and hence should not be used to examine the role of 
this adrenoceptor type. Thus, for the first time this study shows the distribution of 
neutrophils and B cells under adrenergic stimulation in an organism-wide approach. 
Despite these novel findings, which are summarized in Figure 4-1, this thesis also points 
out the knowledge gap in current research on this topic, especially regarding molecular 
mechanisms leading to the observed redistribution of cells in vivo. Furthermore, this study 
demonstrates once more the complexity of this research field, which requires 
methodology allowing for combined analysis of physiological components such as the 
immune system, the nervous system and the circadian clock. Distinct cell types such as 
stromal cells in various organs should be spotlighted for single cell analyses, which will 
facilitate defining the mechanisms leading to adrenergic-driven reallocation of leukocytes 
and tissue-specific effects of the sympathetic tone under steady state. Efforts in this 
respect will be necessary to gain fundamental insight into how the immune system works 






Figure 4-1: Summary figure of the results. 
(A) Administration of the 2-AR agonist Clenbuterol (Clen) leads to the accumulation of 
endogenous neutrophils in blood due to impaired recruitment, whereas B cells presumably migrate 
to lymph nodes where they are retained. Stimulation results in an activated state of B cells and an 
inactivated state of neutrophils, becoming manifest in altered adhesion molecule levels. 2-ARs on 
stromal cells as well as neutrophils are involved in these effects, while for B cells it remains elusive. 
The matrix on the right-hand side displays altered numbers of endogenous (E) and donor (D) B 
cells and neutrophils across blood, bone marrow, liver, lung, lymph nodes and spleen under steady 
state upon Clen administration. (B) Although BRL was found to have unspecific effects due to off-
target binding, egress of neutrophils into blood could be 3-AR specific. In blood, the same 
phenotype as after 2-AR stimulation was observed, so it remains elusive which receptor type is 
responsible. The matrix on the right-hand side displays altered numbers of endogenous (E) and 
donor (D) B cells and neutrophils across blood, bone marrow, liver, lung, lymph nodes and spleen 
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6.1 The SNS influences other circulating leukocyte subsets 
 
 
Figure 6-1: Effects of absence of sympathetic signaling on circulating leukocyte 
numbers. 
Leukocyte numbers in blood after ablation of the sympathetic tone during the day. WT mice were 
injected with PBS (gray) or 6-hydroxydopamine (6-OHDA, white) on day zero and day two, blood 
was harvested at 12 pm on day five of the treatment.  n = 5, student‘s t-test. NK cells = Natural Killer 







Figure 6-2: Changes in blood leukocyte numbers are mediated by 2- and 3-ARs. 
(A) Leukocyte counts in blood upon stimulation of 1-ARs. WT mice were injected with DMSO or 
Denopamine (Den) 2hrs prior to harvest at 12 pm (white) or 8 pm (gray). n = 6, two-way ANOVA, 
Tukey‘s test. (B) Leukocyte counts in blood upon stimulation of 2- and 3-ARs. WT mice were 
injected with PBS, Clenbuterol (Clen) or BRL37344 (BRL) 2hrs prior to harvest at 12 pm (white) 
or 8 pm (gray). n = 5-6, two-way ANOVA, Tukey‘s test. NK cells = Natural Killer cells, Infl. Monos = 






Figure 6-3: Leukocyte counts upon adrenergic stimulation during inflammation. 
Cell counts in blood upon stimulation of 2- and 3-ARs under inflammation. WT mice received 
TNF and PBS or the adrenergic agonists. Blood was harvested at 12 pm (white) or 8 pm (gray). 
n = 5-6, two-way ANOVA, Tukey‘s test. NK cells = Natural Killer cells, Infl. Monos = Inflammatory 
Monocytes, Non-Infl. Monos = Non-Inflammatory Monocytes. 
 
 
Figure 6-4: Time course of harvest time after adrenergic stimulation.  
Cell counts in blood after different times between injection and harvest. n = 3, one-way ANOVA, 
Dunnett‘s test, * test of Clen against PBS, # test of BRL against PBS. NK cells = Natural Killer cells, 







Figure 6-5: Endogenous myeloid cell numbers in various organs upon adrenergic 
stimulation.  
(A) Endogenous myeloid cell counts in blood, two hours after stimulation with Clenbuterol (Clen) 
or BRL37344 (BRL). n = 5-39, one-way ANOVA, Dunnett‘s test. (B) Endogenous myeloid cell counts 
in the bone marrow (BM), 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, 
Dunnett‘s test. (C) Endogenous myeloid cell counts in the liver, 2 hrs after stimulation with Clen or 
BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (D) Endogenous myeloid cell counts in the lung, 2 
hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (E) Endogenous 
myeloid cell counts in the spleen, 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, 
Dunnett‘s test. NK cells = Natural Killer cells, Infl. Monos = Inflammatory Monocytes, Non-Infl. 





Figure 6-6: Ratios of intra- and extravascular endogenous myeloid cells in various 
organs upon adrenergic stimulation.  
(A) Intravascular (white) and extravascular (gray) endogenous myeloid cells in the bone marrow 
(BM) as percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (B) 
Intravascular (white) and extravascular (gray) endogenous myeloid cells in the liver as percentage 
of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (C) Intravascular 
(white) and extravascular (gray) endogenous myeloid cells in the lung as percentage of the 
detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (D) Intravascular (white) and 
extravascular (gray) endogenous myeloid cells in the spleen as percentage of the detected cells in 
this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. NK cells = Natural Killer cells, Infl. Monos = 






Figure 6-7: Donor myeloid cell numbers in various organs upon adrenergic 
stimulation.  
(A) Donor myeloid cell counts in blood, 1 hr after transfer and 2 hrs after stimulation with 
Clenbuterol (Clen) or BRL37344 (BRL). n = 5-6, one-way ANOVA, Dunnett‘s test. (B) Donor myeloid 
cell counts in the bone marrow (BM), 1 hr after transfer and 2 hrs after stimulation with Clen or 
BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (C) Donor myeloid cell counts in the liver, 1 hr after 
transfer and 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (D) 
Donor myeloid cell counts in the lung, 1 hr after transfer and 2 hrs after stimulation with Clen or 
BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (E) Donor myeloid cell counts in the spleen, 1 hr after 
transfer and 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. NK 






Figure 6-8: Ratios of intra- and extravascular donor myeloid cells in various organs 
upon adrenergic stimulation.  
(A) Intravascular (white) and extravascular (gray) donor myeloid cells in the bone marrow (BM) 
as percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (B) 
Intravascular (white) and extravascular (gray) donor myeloid cells in the liver as percentage of the 
detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (C) Intravascular (white) and 
extravascular (gray) donor myeloid cells in the lung as percentage of the detected cells in this 
organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (D) Intravascular (white) and extravascular (gray) 
donor myeloid cells in the spleen as percentage of the detected cells in this organ. n = 5-6, two-way 
ANOVA, Dunnett‘s test. NK cells = Natural Killer cells, Infl. Monos = Inflammatory Monocytes, Non-






Figure 6-9: Endogenous lymphoid cell numbers in various organs upon adrenergic 
stimulation.  
(A) Endogenous lymphoid cell counts in blood, 2 hrs after stimulation with Clenbuterol (Clen) or 
BRL37344 (BRL). n = 36-39, one-way ANOVA, Dunnett‘s test. (B) Endogenous lymphoid cell counts 
in the bone marrow (BM), 2 hrs after stimulation with Clen or BRL. n = 11-12, one-way ANOVA, 
Dunnett‘s test. (C) Endogenous lymphoid cell counts in the liver, 2 hrs after stimulation with Clen 
or BRL. n = 11-12, one-way ANOVA, Dunnett‘s test. (D) Endogenous lymphoid cell counts in the 
lung, 2 hrs after stimulation with Clen or BRL. n = 11-12, one-way ANOVA, Dunnett‘s test. (E) 
Endogenous lymphoid cell counts in the spleen, 2 hrs after stimulation with Clen or BRL. n = 5-6, 
one-way ANOVA, Dunnett‘s test. (F) Endogenous lymphoid cell counts in two iLNs, 2 hrs after 
stimulation with Clen or BRL. n = 8-9, one-way ANOVA, Dunnett‘s test. (G) Endogenous lymphoid 
cell counts in the mLN, 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s 
test. (H) Endogenous lymphoid cell counts in two spLNs, 2 hrs after stimulation with Clen or BRL. 
n = 5-6, one-way ANOVA, Dunnett‘s test. (I) Endogenous lymphoid cell counts in pooled Peyer´s 
Patches, 2 hrs after stimulation with Clen or BRL. n = 6, one-way ANOVA, Dunnett‘s test. iLN = 







Figure 6-10: Ratios of intra- and extravascular endogenous lymphoid cells in 
various organs upon adrenergic stimulation.  
(A) Intravascular (white) and extravascular (gray) endogenous lymphoid cells in the BM as 
percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (B) 
Intravascular (white) and extravascular (gray) endogenous lymphoid cells in the liver as 
percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (C) 
Intravascular (white) and extravascular (gray) endogenous lymphoid cells in the lung as 
percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (D) 
Intravascular (white) and extravascular (gray) endogenous lymphoid cells in the spleen as 
percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (E) 
Intravascular (white) and extravascular (gray) endogenous lymphoid cells in two iLN as 
percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (F) 
Intravascular (white) and extravascular (gray) endogenous lymphoid cells in the mLN as 
percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (G) 
Intravascular (white) and extravascular (gray) endogenous lymphoid cells in two spLNs as 
percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. BM = bone 








Figure 6-11: Donor lymphoid cell numbers in various organs upon adrenergic 
stimulation.  
(A) Donor lymphoid cell counts in blood, 2 hrs after stimulation with Clenbuterol (Clen) or 
BRL37344 (BRL). n = 5-6, one-way ANOVA, Dunnett‘s test. (B) Donor lymphoid cell counts in the 
BM, 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (C) Donor 
lymphoid cell counts in the liver, 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, 
Dunnett‘s test. (D) Donor lymphoid cell counts in the lung, 2 hrs after stimulation with Clen or BRL. 
n = 5-6, one-way ANOVA, Dunnett‘s test. (E) Donor lymphoid cell counts in the spleen, 2 hrs after 
stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (F) Donor lymphoid cell 
counts in two iLNs, 2 hrs after stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s 
test. (G) Donor lymphoid cell counts in the mLN, 2 hrs after stimulation with Clen or BRL. n = 5-6, 
one-way ANOVA, Dunnett‘s test. (H) Donor lymphoid cell counts in two spLNs, 2 hrs after 
stimulation with Clen or BRL. n = 5-6, one-way ANOVA, Dunnett‘s test. (I) Donor lymphoid cell 
counts in pooled Peyer´s Patches, 2 hrs after stimulation with Clen or BRL. n = 3, one-way ANOVA, 
Dunnett‘s test. BM = bone marrow, iLN = inguinal lymph node, mLN = mesenteric lymph node, 









Figure 6-12: Ratios of intra- and extravascular donor lymphoid cells in various 
organs upon adrenergic stimulation.  
(A) Intravascular (white) and extravascular (gray) donor lymphoid cells in the BM as percentage 
of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (B) Intravascular 
(white) and extravascular (gray) donor lymphoid cells in the liver as percentage of the detected 
cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (C) Intravascular (white) and 
extravascular (gray) donor lymphoid cells in the lung as percentage of the detected cells in this 
organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (D) Intravascular (white) and extravascular (gray) 
donor lymphoid cells in the spleen as percentage of the detected cells in this organ. n = 5-6, two-
way ANOVA, Dunnett‘s test. (E) Intravascular (white) and extravascular (gray) donor lymphoid 
cells in two iLNs as percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, 
Dunnett‘s test. (F) Intravascular (white) and extravascular (gray) donor lymphoid cells in the mLN 
as percentage of the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (G) 
Intravascular (white) and extravascular (gray) donor lymphoid cells in two spLNs as percentage of 
the detected cells in this organ. n = 5-6, two-way ANOVA, Dunnett‘s test. (H) Intravascular (white) 
and extravascular (gray) donor lymphoid cells in pooled Peyer´s Patches as percentage of the 
detected cells in this organ. n = 3, two-way ANOVA, Dunnett‘s test. BM = bone marrow, iLN = 






Figure 6-13: Summary of cell distributions upon Clenbuterol administration. 
Increased, decreased or unchanged endogenous and donor cell numbers of CD4+ T cells, CD8+ T 
cells, NK cells, inflammatory monocytes, non-inflammatory monocytes and eosinophils in various 
organs 2 hrs after injection of Clenbuterol (Clen). BM = bone marrow, LNs = lymph nodes, Endo = 
endogenous, CD4+ = CD4+ T cells, CD8+ = CD8+ T cells, NK = Natural Killer cells, Infl. Monos = 






Figure 6-14: Leukocyte numbers in blood and lymph nodes upon egress block. 
(A) Fraction of leukocytes in blood after egress block with FTY720 and adrenergic stimulation. WT 
mice were intraperitoneally injected with PBS or FTY720 and directly afterwards with PBS, Clen 
or BRL. At 12 pm blood was harvested and processed for flow cytometry. n = 3, two-way ANOVA, 
Tukey‘s test; * test against PBS+PBS, # test against indicated group. (B) Fraction of leukocytes in 
gut-draining lymph node after egress block with FTY720 and adrenergic stimulation. WT mice 
were intraperitoneally injected with PBS or FTY720 and directly afterwards with PBS, Clen or BRL. 
At 12 pm, the mesenteric lymph node was harvested and processed for flow cytometry n = 3, two-
way ANOVA, Tukey‘s test. (C) Fraction of leukocytes in skin-draining lymph nodes after egress 
block with FTY720 and adrenergic stimulation. WT mice were intraperitoneally injected with PBS 
or FTY720 and directly afterwards with PBS, Clen or BRL. At 12 pm, eight sdLNs were harvested, 
pooled and processed for flow cytometry. n = 3, two-way ANOVA, Tukey‘s test. gdLN = gut-draining 
lymph node, sdLN = skin-draining lymph node, WBC = White blood cells, NK cells = Natural Killer 
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